KR20200058932A - Hair loss prevention and hair growth improving composition containing a bellflower extract or a bellflower fractio - Google Patents

Hair loss prevention and hair growth improving composition containing a bellflower extract or a bellflower fractio Download PDF

Info

Publication number
KR20200058932A
KR20200058932A KR1020180143660A KR20180143660A KR20200058932A KR 20200058932 A KR20200058932 A KR 20200058932A KR 1020180143660 A KR1020180143660 A KR 1020180143660A KR 20180143660 A KR20180143660 A KR 20180143660A KR 20200058932 A KR20200058932 A KR 20200058932A
Authority
KR
South Korea
Prior art keywords
hair
bellflower
fraction
extract
hair loss
Prior art date
Application number
KR1020180143660A
Other languages
Korean (ko)
Inventor
정민화
Original Assignee
대동대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대동대학교 산학협력단 filed Critical 대동대학교 산학협력단
Priority to KR1020180143660A priority Critical patent/KR20200058932A/en
Publication of KR20200058932A publication Critical patent/KR20200058932A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a composition for preventing hair loss and improving hair growth, wherein the composition comprises any one fraction selected from an ethanol extract of bellflower root, a chloroform fraction of bellflower root, an ethylacetate fraction of bellflower root, a butanol fraction of bellflower root, and a water fraction of bellflower root. In addition, it can be seen that the composition for preventing hair loss and improving hair growth has no toxicity to dermal papilla cells and also has an effect of increasing cell growth and decreasing an amount of DHT production near 50%, thereby providing an excellent effect of improving hair growth. The composition of the present invention also comprises a natural material as an effective component so the composition is hypoallergenic and excellently safe to the skin, and thus can be mixed in a variety of hair cosmetics and used in various dosage forms.

Description

도라지 추출물 또는 도라지 분획물을 함유하는 탈모예방 및 탈모개선 조성물{Hair loss prevention and hair growth improving composition containing a bellflower extract or a bellflower fractio}Hair loss prevention and hair growth improving composition containing a bellflower extract or a bellflower fractio}

본 발명은 도라지 추출물 또는 도라지 분획물을 유효성분으로 함유하는 탈모예방 및 발모개선 조성물에 관한 것이며, 구체적으로는 항염증효과, 탈모의 원인이 되는 Dihydro- testosterone 생성저해 효과 및 항균활성효과가 우수한 도라지 추출물 또는 도라지 분획물을 유효성분으로 함유하는 탈모예방 및 발모개선 조성물에 관한 것이다.The present invention relates to a hair loss prevention and hair growth improvement composition containing a bellflower extract or a bellflower fraction as an active ingredient, specifically, an anti-inflammatory effect, a dihydro-testosterone production inhibitory effect that causes hair loss, and a bellflower extract excellent in antibacterial activity effect Or it relates to a hair loss prevention and hair growth improvement composition containing a bellflower fraction as an active ingredient.

인체의 모발은 두상 및 두피 보호라는 목적 외에, 미적, 성적인 측면에서 중요성이 인정되고 있으므로 탈모현상은 현대인의 고민거리 중에 하나이지만, 탈모의 정확한 기전은 알려져 있지 않으며, 환경적, 유전적, 정신적, 신체적, 등 여러 가지 원인으로 신체적 리듬이 깨져 밸런스가 맞지 않아 두피뿐만 아니라 모낭에도 크게 영향을 미쳐 모발 손상은 물론이고 탈모로 이어지고 있다.In addition to the purpose of protecting the hair and scalp of human body, the importance of hair loss is recognized in terms of aesthetics and sexuality, but the exact mechanism of hair loss is unknown, and environmental, genetic, and mental The physical rhythm is broken due to various causes such as physical and back, and the balance is not balanced, which greatly affects not only the scalp but also the hair follicle, leading to hair loss and hair loss.

탈모인구가 급격히 늘어남에 따라 두피케어 탈모 방지 헤어케어 제품의 수요가 크게 증가하고 있고 이와 관련된 연구개발이 많이 진행되었지만 아직 제대로 된 소재개발은 미미한 편이다. 현재까지 탈모치료제로 공인받은 제품은 Finasteride와 Minoxidil이 있지만 이 두 제품은 부작용이 알려져 있고, 아직 발모효능 물질은 제대로 개발되어 있지 않으며, 이러한 부작용의 문제점을 최소화한 새로운 천연물질 유래 탈모 치료제의 개발이 필요한 실정으로 지금까지 이러한 연구가 지속적으로 이뤄지고 있다.With the rapidly growing hair loss population, the demand for scalp care hair loss prevention hair care products has increased significantly, and there have been many research and development related to this, but the material development is still insignificant. Until now, products approved for hair loss treatment include Finasteride and Minoxidil, but these two products have known side effects, and hair growth efficacy substances have not been properly developed. These studies have been continuously conducted so far as necessary.

천연물을 이용한 탈모 방지와 관련한 선행기술로 예를 들면, 특허문헌1에 감국, 홍화, 금잔화, 금은화, 선복화 및 오소리 오일의 복합 추출물을 유효성분으로 포함하는 것을 특징으로 하는 탈모방지 및 모발 생장 촉진용 두발 화장료 조성물이 개시되어 있으며 또, 특허문헌2에 탈모 방지 및 모발 생장 촉진용 한방 조성물로서: 상기 한방 조성물 총량에 대하여, 상황버섯 추출물 20 내지 25중량%, 황금 추출물 20 내지 25중량%, 목단피추출물 15 내지 20중량%, 산수유 추출물 5 내지 10중량%, 칡 추출물 5 내지 10중량%, 고삼 추출물 5 내지 10중량%, 숙지황 추출물 5 내지 10중량%, 녹차잎 추출물 5 내지 10중량%, 금은화 추출물 5 내지 10중량%, 실크 추출물과 황련 추출물과 상백피 추출물로부터 선택되는 적어도 하나의 추출물 5 내지 10중량%를 포함하는 한방 추출물; 및 상기 한방 조성물 총량에 대하여, 제니스테인(genistein) 1 내지 2중량% 및 레스베라트롤(resveratrol) 1 내지 2중량%를 포함하는 폴리페놀;을 포함하는 탈모 방지 및 모발 생장 촉진용 한방 조성물을 개시하고 있다.As a prior art related to the prevention of hair loss using natural substances, for example, patent document 1 includes a complex extract of chrysanthemum, safflower, marigold, gold silver, bokbok and badger oil as an active ingredient, preventing hair loss and promoting hair growth The hair cosmetic composition for dragon hair is disclosed, and as a herbal composition for preventing hair loss and promoting hair growth in Patent Document 2: 20 to 25% by weight, Phellinus linteus extract, 20 to 25% by weight, golden extract 20 to 25% by weight, based on the total amount of the herbal composition 15 to 20% by weight of extract, 5 to 10% by weight of Cornus officinalis extract, 5 to 10% by weight of 고 extract, 5 to 10% by weight of ginseng extract, 5 to 10% by weight of succinate extract, 5 to 10% by weight of green tea leaf extract, extract of gold and silver coins 5 to 10% by weight, herbal extracts containing 5 to 10% by weight of at least one extract selected from silk extracts and hwangnyeon extracts and epidermis extracts; And with respect to the total amount of the herbal composition, genistein (genistein) 1 to 2% by weight and resveratrol (resveratrol) 1 to 2% by weight of polyphenols; including hair loss prevention and hair growth promoting herbal composition disclosed.

또 특허문헌3에는 식물 재료의 전체 중량을 기준으로, 인삼 6 내지 12중량%, 검은콩 10 내지 15중량%, 어성초 6 내지 12중량%, 구기자 6 내지 12중량%, 감초 10 내지 15중량%, 진피 6 내지 12중량%, 대추 6 내지 12중량%, 자소엽 6 내지 12중량%, 녹차잎 10 내지 15중량% 및 백하수오 6 내지 10중량%를 함유하는 식물 재료로부터 추출되는 식물추출물로서, 인간진피모유두 세포(HFDPC)의 5α-환원효소 발현을 억제하고, 인간진피모유두 세포(HFDPC)의 β-카테닌 발현을 촉진하는 식물 추출물을 포함하는 탈모 방지 및 발모 개선용 조성물을 개시하고 있다.In addition, Patent Document 3, based on the total weight of the plant material, 6 to 12% by weight of ginseng, 10 to 15% by weight of black beans, 6 to 12% by weight of Eoseongcho, 6 to 12% by weight of wolfberry, 10 to 15% by weight of licorice, As a plant extract extracted from plant materials containing 6 to 12% by weight of dermis, 6 to 12% by weight of jujube, 6 to 12% by weight of cotyledon, 10 to 15% by weight of green tea leaves and 6 to 10% by weight of white sorghum, Disclosed is a composition for preventing hair loss and improving hair growth, comprising a plant extract that inhibits 5α-reductase expression of dermal papilla cells (HFDPC) and promotes β-catenin expression of human dermal papilla cells (HFDPC).

본 발명의 출원인은 천연물인 도라지 추출물과 분획물들이 항산화 효과와 피부세포 재생효과, NO 및 PGE2 생성을 줄이는 항염증효과, 탈모의 원인이 되는 Dihydro- testosterone 생성저해 효과를 보여주어 탈모방지 천연추출물로의 가능성을 확인하고본 발명을 완성하였다.Applicants of the present invention are natural extracts of bellflower extract and fractions that show antioxidant and skin cell regeneration effects, anti-inflammatory effects that reduce NO and PGE 2 production, and dihydro-testosterone production inhibitory effects that cause hair loss. Confirmed the possibility and completed the present invention.

특허문헌1; 대한민국 등록특허공보 등록번호 10-1009763호Patent Document 1; Republic of Korea Registered Patent Publication No. 10-1009763 특허문헌2; 대한민국 등록특허공보 등록번호 10-1440046호Patent Document 2; Republic of Korea Registered Patent Publication No. 10-1440046 특허문헌3; 대한민국 등록특허공보 등록번호 10-1758998호Patent Document 3; Republic of Korea Registered Patent Publication No. 10-1758998

본 발명에서 해결하고자 하는 과제는 도라지 추출물 또는 도라지 분획물을 유효성분으로 함유하는 탈모예방 및 발모개선 조성물의 제공에 관한 것이며, 보다 상세하게는 항산화 효과와 피부세포 재생효과, NO 및 PGE2 생성을 줄이는 항염증효과, 탈모의 원인이 되는 Dihydro- testosterone 생성저해 효과가 우수한 도라지 추출물 또는 도라지 분획물을 유효성분으로 함유하는 탈모예방 및 발모개선 조성물의 제공을 목적으로 하는 것이다.The problem to be solved in the present invention is to provide a hair loss prevention and hair growth improvement composition containing a bellflower extract or a bellflower fraction as an active ingredient, and more specifically, reducing antioxidant and skin cell regeneration effects, reducing NO and PGE 2 production. It is an object of the present invention to provide a composition for preventing hair loss and improving hair growth, which contains an anti-inflammatory effect and a bellflower extract or a bellflower fraction having an excellent effect of inhibiting the production of dihydro-testosterone that causes hair loss.

본 발명에 따른 과제의 해결 수단으로 도라지 추출물 또는 도라지 분획물을 함유하는 탈모예방 및 발모개선 조성물은 도라지 에탄올 추출물 또는 도라지 에탄올 추출물로부터 수득한 도라지 클로로포름 분획물, 도라지 에틸아세테이트 분획물, 도라지부탄올 분획물 및 도라지 물 분획물 중에서 선택되는 하나 이상의 도라지 분획물을 유효성분으로 함유하는 것으로 이루어진다.As a solution for solving the problems according to the present invention, a hair loss prevention and hair growth improvement composition containing a bellflower extract or a bellflower fraction is a bellflower chloroform fraction, a bellflower ethyl acetate fraction, a bellflower butanol fraction and a bellflower water fraction obtained from a bellflower ethanol extract or a bellflower ethanol extract It consists of containing at least one bellflower fraction selected from the active ingredient.

상기 본 발명의 도라지 추출물 또는 도라지 분획물을 함유하는 탈모예방 및 발모개선 조성물에 따른 일 실시형태는 조성물 전체 중량에 대하여 유효성분으로 도라지 에탄올 추출물 또는 도라지 에탄올 추출물로부터 수득한 도라지 클로로포름 분확물, 도라지 에틸아세테이트 분획물, 도라지 부탄올 분획물 및 도라지 물 분획물 중에서 선택되는 하나 이상의 도라지 분획물을 0.1 ~ 80중량% 함유하는 것으로 이루어진다.One embodiment according to the hair loss prevention and hair growth improvement composition containing the bellflower extract or the bellflower fraction of the present invention is a bellflower chloroform obtained from a bellflower ethanol extract or a bellflower ethanol extract as an active ingredient relative to the total weight of the composition, a bellflower ethylacetate It consists of 0.1 to 80% by weight of at least one bellflower fraction selected from fractions, bellflower butanol fraction and bellflower water fraction.

본 발명의 과제의 해결수단으로 도라지 추출물 또는 도라지 분획물을 함유하는 탈모예방 및 발모개선 조성물에 따른 또 다른 실시 형태는 본 발명의 조성물을 함유한 헤어토닉, 헤어컨디셔너, 헤어에센스, 헤어로션, 헤어영양로션, 헤어샴푸, 헤어린스, 헤어트리트먼트, 헤어크림, 헤어영양크림, 헤어모이스처크림, 헤어맛사지크림, 헤어왁스, 헤어 에어로졸, 헤어팩, 헤어영양팩, 헤어비누, 헤어클렌징폼, 머릿기름, 모발건조제, 모발보존처리제, 모발염색제, 모발용 웨이브제, 모발탈색제, 헤어겔, 헤어글레이즈, 헤어드레싱어, 헤어래커, 헤어모이스처라이저, 헤어무스 및 헤어스프레이 중 어느 하나의 제형으로 이루어진다.Another embodiment according to the hair loss prevention and hair growth improvement composition containing a bellflower extract or a bellflower fraction as a solution of the problems of the present invention is a hair tonic, a hair conditioner, a hair essence, a hair lotion, and hair nutrition containing the composition of the present invention Lotion, hair shampoo, hair rinse, hair treatment, hair cream, hair nutrition cream, hair moisture cream, hair massage cream, hair wax, hair aerosol, hair pack, hair nutrition pack, hair soap, hair cleansing foam, hair oil, hair dryer , Hair preservation treatment agent, hair dye, hair wave agent, hair decolorant, hair gel, hair glaze, hair dresser, hair lacquer, hair moisturizer, hair mousse and hair spray.

본 발명의 탈모예방 및 발모개선 조성물에 유효성분으로 함유하는 도라지 에탄올 추출물 항산화 효과와 피부세포 재생효과, NO 및 PGE2 생성을 줄이는 항염증효과, 탈모의 원인이 되는 Dihydro- testosterone 생성저해 효과가 있으며 또 도라지 클로로포름과 에틸아세테이트 분획물은 비듬균의 생육을 억제하는 항균활성효과, 모유두세포 증식효능이 있으므로 탈모예방 및 발모 효과를 나타내며, 헤어케어 제품에 적용할 수 있는 장점이 있다.There is an antioxidant effect of bellflower ethanol extract containing as an active ingredient in the hair loss prevention and hair growth improvement composition of the present invention, skin cell regeneration effect, anti-inflammatory effect to reduce NO and PGE 2 production, and dihydro-testosterone production inhibitory effect that causes hair loss. In addition, the bellflower chloroform and ethyl acetate fraction show anti-hair loss and hair growth effects because they have antibacterial activity effects that inhibit the growth of dandruff bacteria and proliferation of dermal papilla cells, and have the advantage of being applied to hair care products.

도 1은 본 발명의 도라지 에탄올 추출물의 DPPH radical 소거능 및 ABTS radical 소거능에 대한 도표
도 2는 본 발명의 도라지 에탄올 추출물의 피부세포 재생효과에 대한 도표
도 3은 본 발명의 도라지 에탄올 추출물의 PGE2 저해활성에 대한 도표
도 4는 본 발명의 도라지 에탄올 추출물의 모유두세포 증식활성에 대한 도표
도 5는 본 발명의 도라지 에탄올 추출물 및 대조군의 DHT 생성량에 대한 도표
도 6은 본 발명의 도라지 분획물들의 DPPH radical 소거능 및 ABTS radical 소거능에 대한 도표
도 7은 본 발명의 도라지 분획물들의 피부세포독성에 대한 도표
도 8 및 도 9는 본 발명의 도라지 분획물들의 피부세포재생효과에 대한 도표
도 10은 본 발명의 도라지 분획물들 및 대조군의 RAW264.7 세포독성에 대한 도표
도 11은 본 발명의 도라지 클로르포름 및 에틸아세테이트 분획물과 대조군의 PGE2 저해활성에 대한 도표
도 12는 본 발명의 도라지 분획물들의 모유두세포에 대한 독성확인 도표
도 13은 본 발명의 도라지 분획물들의 대조군의 DHT 생성량에 대한 도표
1 is a diagram of DPPH radical scavenging activity and ABTS radical scavenging ability of the bellflower ethanol extract of the present invention
Figure 2 is a chart for the skin cell regeneration effect of the bellflower ethanol extract of the present invention
Figure 3 is a chart for PGE 2 inhibitory activity of the bellflower ethanol extract of the present invention
Figure 4 is a chart for proliferation activity of dermal papilla cells of the bellflower ethanol extract of the present invention
Figure 5 is a chart for the amount of DHT production of bellflower ethanol extract and control of the present invention
6 is a diagram of DPPH radical scavenging activity and ABTS radical scavenging ability of bellflower fractions of the present invention
7 is a chart for skin cytotoxicity of bellflower fractions of the present invention
8 and 9 is a chart for the skin cell regeneration effect of the bellflower fractions of the present invention
10 is a diagram for RAW264.7 cytotoxicity of bellflower fractions and controls of the present invention
11 is a chart for PGE 2 inhibitory activity of the bellflower chlorform and ethyl acetate fractions of the present invention and the control group
12 is a toxicity confirmation chart for dermal papilla cells of the bellflower fractions of the present invention
13 is a chart for the amount of DHT production of the control of bellflower fractions of the present invention

아래에서는 본 발명을 실시하기 위한 구체적인 내용, <실시예> 및 <시험예>를 통하여 본 발명을 보다 구체적으로 설명하는 것이지만, 본 발명의 실시형태는 여러 가지 다른 형태로 변형될 수 있으므로 본 발명의 범위가 아래 설명하는 실시형태로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through specific contents for carrying out the present invention, <Examples> and <Test Examples>, but the embodiments of the present invention may be modified in various other forms, so that the present invention The scope is not limited to the embodiments described below.

본 발명에 따른 도라지 추출물 또는 도라지 분획물을 함유하는 탈모방지 및 발모개선 조성물은 조성물 전체 중량에 대하여 유효성분으로 도라지 에탄올 추출물 또는 도라지 에탄올 추출물로부터 수득한 도라지 클로로포름 분확물, 도라지 에틸아세테이트 분획물, 도라지 부탄올 분획물 및 도라지 물 분획물 중에서 선택되는 하나 이상의 도라지 분획물을 0.1 ~ 80중량% 함유하는 것으로 이루어진다.The hair loss prevention and hair growth improvement composition containing the bellflower extract or bellflower fraction according to the present invention is a bellflower chloroform fraction obtained from an bellflower ethanol extract or a bellflower ethanol extract, an bellflower ethyl acetate fraction, a bellflower butanol fraction as an active ingredient relative to the total weight of the composition And 0.1 to 80% by weight of at least one bellflower fraction selected from bellflower water fractions.

본 발명에 따른 상기 도라지 에탄올 추출물은 70%(v/v)의 에탄올을 추출용매로 하여 35℃에서 추출한다.The bellflower ethanol extract according to the present invention is extracted at 35 ° C using 70% (v / v) of ethanol as an extraction solvent.

상기 도라지 분획물들은 상기한 도라지 에탄올 추출물에 클로로포름, 에틸아세테이트 및 부탄올를 순차 첨가하고 극성차이에 따라 층이 분리되는 성질을 이용하여 각각 분리하여 도라지 클로로포름 분획물, 도라지 에틸아세테이트 분획물, 도라지 부탄올 분획물 및 도라지 물 분획물을 수득한다. The bellflower fractions are chloroform, ethyl acetate and butanol sequentially added to the above-mentioned bellflower ethanol extract, and separated by using the property that the layers are separated according to polarity differences, respectively, to thereby separate the bellflower chloroform fraction, the bellflower ethyl acetate fraction, the bellflower butanol fraction and the bellflower water fraction. To obtain

아래에서는 <실시예> 및 <시험예>를 통하여 본 발명을 구체적으로 설명하기로 하며, 아래 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용을 한정하는 것은 아니다.Hereinafter, the present invention will be described in detail through <Examples> and <Test Examples>, and the examples below are only intended to illustrate the present invention and do not limit the contents of the present invention.

<실시예 1> 도라지 에탄올 추출물의 제조<Example 1> Preparation of bellflower ethanol extract

지리산 도덕농원으로부터 구입한 2018년산 3년생 장생도라지를 깨끗하게 정선한 다음 세절하여 40℃에서 24시간 열풍 건조하고 분쇄하여 분말로 하였다.A freshly picked 3-year-old Jangsaeng Doraji, purchased from Jiri Mountain's Moral Farm, was carefully selected, then shredded to dryness at 40 ° C for 24 hours, pulverized to form a powder.

상기 도라지 분말에 대하여 10배의 부피비율로 70% 에탄올을 첨가하고 35℃에서 48 시간동안 교반하여 2회 추출하여 수득한 추출물을 감압여과(여과지 No.2)하고 감압농축기(EYERA Rotary Evaporator N-1000)로 추출용매를 제거한 다음, 이 농축물을 시료로 하고, 최고농도를 200mg/㎖까지 설정하여 이 후 in vitro 시험을 진행한다.70% ethanol was added at a volume ratio of 10 times to the bellflower powder, and the mixture was extracted twice by stirring at 35 ° C for 48 hours, and the resulting extract was filtered under reduced pressure (filter paper No. 2) and concentrated under reduced pressure (EYERA Rotary Evaporator N- After removing the extraction solvent with 1000), this concentrate is used as a sample, and the highest concentration is set to 200 mg / ml, and then an in vitro test is performed.

<실시예 2> 도라지 분획물들의 분리<Example 2> Separation of bellflower fractions

분액깔때기를 이용하여 상기 <실시예1>에서 수득한 에탄올 추출물을증류수에 용해시킨 다음 클로로포름을 첨가하여 정치시킨 후 클로로포름층을 분리하여 도라지 클로로포름 분획물을 수득한다.The ethanol extract obtained in <Example 1> was dissolved in distilled water using a separating funnel, and then left to stand by adding chloroform to separate the chloroform layer to obtain a bellflower chloroform fraction.

상기 잔여 용액에 에틸아세테이트를 첨가하여 정치한 다음 에틸아세데이트층을 분리하여 도라지 에틸아세테이트 분획물을 수득하고, 도라지 에틸아세테이트 분획물을 분리한 잔여 용액에 부탄올을 첨가하여 부탄올층을 분리하여 도라지부탄올 분획물을 수득하고, 최종적으로 남은 도라지 물 분획물을 얻었다.Ethyl acetate was added to the remaining solution to stand, and then the ethyl acetate layer was separated to obtain a bellflower ethyl acetate fraction, and the butanol layer was separated by adding butanol to the remaining solution from which the bellflower ethyl acetate fraction was separated to separate the bellflower butanol fraction. Obtained and finally the remaining bellflower water fraction was obtained.

상기 분리된 각각의 분확물로부터 용매 추출물를 감압 농축으로 용매를 제거한 후 농축물을 DMSO에 용해시킨 상기 도라지 크로로포름 분획물, 도라지 에틸아세테이트 분획물, 도라지 부탄올 분획물, 도라지 물 분획물을 시료로 하여 시험한다.After removing the solvent from each separated fraction by concentration under reduced pressure, the solvent extract is tested with a sample of the bellflower chloroform fraction, bellflower ethyl acetate fraction, bellflower butanol fraction, bellflower water fraction dissolved in DMSO as a sample.

A. A. 도라지 에탄올 추출물의 탈모예방 및 발모개선 효능 시험Prevention of hair loss and improvement of hair growth efficacy of bellflower ethanol extract

<시험예 1> 항산화 활성<Test Example 1> antioxidant activity

탈모의 원인은 유전적 요인과 환경적 요인이 있으며, 환경적 요인은 활성산소와 밀접한 관련이 있다. 활성산소는 산화작용으로 노화를 촉진하고 모발의 활력을 감소시킨다. 게다가 콜레스테롤과 결합하여 과산화 지질로 변하게 되고 혈관 벽에 붙게 되어 두피 혈관을 좁게 하고 모공을 막아 혈류를 감소시켜 모근에 영양 공급을 어렵게 한다. 또한, 모낭을 구성하는 세포의 세포막을 손상시켜 세포 사멸을 일으키고 두피 염증을 일으켜 탈모를 일으킨다. 도라지 에탄올 추출물의 항산화 활성을 확인하기 위하여 DPPH와 ABTS Radical 소거능을 측정하였다.The causes of hair loss are genetic and environmental factors, and environmental factors are closely related to free radicals. Reactive oxygen promotes aging through oxidation and reduces hair vitality. In addition, it binds to cholesterol and turns into lipid peroxide and sticks to the walls of blood vessels, narrowing the blood vessels of the scalp and clogging pores, reducing blood flow, making it difficult to supply nutrients to the hair roots. In addition, it damages the cell membrane of the cells constituting the hair follicles, causing cell death and causing scalp inflammation to cause hair loss. DPPH and ABTS Radical scavenging activity were measured to confirm the antioxidant activity of the bellflower ethanol extract.

1). DPPH radical 소거능 One). DPPH radical scavenging ability

DPPH assay 방법은 Yoshida et al. (1989)이 사용한 방법에 따라 측정하였다. 96 well plate에 control에는 탈이온수 50㎕, 시험군에는 탈이온수로 희석한 시료를 5㎕ 씩 triple로 넣는다. 에탄올을 모든 웰에 25㎕씩 넣고, 75㎕의 DPPH (0.5mM 1,1-diphenyl-2- picrylhydrazyl) 용액을 가하여 혼합한다. 25℃의 실온에서 30분 동안 반응시킨 후 517 nm에서 흡광도를 측정하였다. 용매 대조군으로 하여 대조군에 대한 라디칼 소거능을 아래 [계산식1]과 같이 백분율로 나타내었으며, 그 결과를 아래 [표 1] 및 [도 1]로 나타내었다.  The DPPH assay method is described in Yoshida et al. (1989). 50 μl of deionized water is added to the control of a 96 well plate, and 5 μl of a sample diluted with deionized water is added to the test group as triples. Add 25 µl of ethanol to all wells, add 75 µl of DPPH (0.5 mM 1,1-diphenyl-2- picrylhydrazyl) solution and mix. After reacting at room temperature for 25 minutes for 30 minutes, absorbance was measured at 517 nm. As a solvent control group, the radical scavenging ability of the control group was expressed as a percentage as shown in [Calculation Formula 1] below, and the results are shown in [Table 1] and [Figure 1] below.

[계산식 1][Calculation formula 1]

Figure pat00001
Figure pat00001

2). ABTS radical 소거능 2). ABTS radical scavenging ability

ABTS assay 방법은 Re et al.(1999)의 방법을 변형하여 측정하였다. 즉, 7mM ABTS 5㎖와 140mM potassium persulfate 88㎕를 섞은 후 상온에서 16시간 빛을 차단하여 ABTS 양이온을 형성시킨다. 이후 이 용액을 414nm에서 흡광도 값이 1.5가 되도록 PBS로 희석하였다. 조제된 희석용액 190㎕와 시료 10㎕를 혼합한 후 상온에서 6분간 반응시킨 후 734nm에서 흡광도를 측정하였다. 용매 대조군으로 하여 대조군에 대한 라디칼 소거능을 아래 [계산식1]과 같이 백분율로 나타내었으며 그 결과를 아래 [표 1] 및 [도 1]로 나타내었다.  The ABTS assay method was measured by modifying the method of Re et al. (1999). That is, after mixing 5 ml of 7 mM ABTS and 88 μl of 140 mM potassium persulfate, the light is blocked for 16 hours at room temperature to form ABTS cations. The solution was then diluted with PBS so that the absorbance value at 414 nm was 1.5. After 190 µl of the prepared dilution solution and 10 µl of the sample were mixed and reacted for 6 minutes at room temperature, the absorbance was measured at 734 nm. As a solvent control group, the radical scavenging ability of the control group was expressed as a percentage as shown in [Calculation Formula 1] below, and the results are shown in [Table 1] and [Figure 1] below.

[계산식 2][Calculation formula 2]

Figure pat00002
Figure pat00002

시료농도(mg/㎖)Sample concentration (mg / ml) DPPH 라디칼 소거능(%)DPPH radical scavenging ability (%) ABTS 라디칼 소거능(%)ABTS radical scavenging capacity (%) 1One 13.3±5.413.3 ± 5.4 10.0±1.910.0 ± 1.9 1010 31.5±1.031.5 ± 1.0 24.6±2.524.6 ± 2.5 5050 57.5±2.257.5 ± 2.2 99.9±0.299.9 ± 0.2 100100 90.0±7.590.0 ± 7.5 99.7±0.299.7 ± 0.2 200200 90.3±3.390.3 ± 3.3 100.0±0.4100.0 ± 0.4 *IC50 : DPPH 42.9㎎/㎖, ABTS 23.1㎎/㎖* IC 50 : DPPH 42.9mg / ml, ABTS 23.1mg / ml

상기 [표 1]에나타난 바와같이 에탄올 추출물의 Radical 소거능은 농도 의존적으로 활성이 증가하였다. 도라지 에탄올 추출물의 DPPH 라디칼 소거활성은 50㎎/㎖의 농도에서 57.5%의 활성을, ABTS 라디칼 소거활성은 10㎎/㎖의 농도에서 24.6%의 소거활성을 보여 주었다. DPPH 라디칼 소거능보다 ABTS 라디칼 소거능이 더 높았다.As shown in [Table 1], the activity of Radical scavenging of ethanol extract increased concentration-dependently. DPPH radical scavenging activity of bellflower ethanol extract showed 57.5% of activity at a concentration of 50 mg / ml, and ABTS radical scavenging activity of 24.6% at a concentration of 10 mg / ml. ABTS radical scavenging ability was higher than DPPH radical scavenging ability.

<시험예 2> 피부세포 독성 및 세포재생 효능평가 시험<Test Example 2> Skin cell toxicity and cell regeneration efficacy evaluation test

1). 세포주 및 배양 One). Cell lines and culture

시료의 피부세포 독성을 알아보기 위하여 인간 유래의 표피세포인 HaCaT 세포를 통해 세포의 독성을 측정하였다. 즉, 세포 배양용 플라스크에 배양한 HaCaT 세포주를 10㎖ 피펫으로 세포를 플라스크에서 떼어내어 계대하였고, 세포는 10% FBS가 함유된 DMEM/LOW 배지로 배양하였다.  To examine the skin cell toxicity of the sample, the cell toxicity was measured through HaCaT cells, which are human-derived epidermal cells. That is, the HaCaT cell line cultured in the cell culture flask was passaged by removing the cells from the flask with a 10 ml pipette, and the cells were cultured with DMEM / LOW medium containing 10% FBS.

2). 세포독성시험 2). Cytotoxicity test

HaCaT cell은 96 well plate에 1x104/well로 분주하여 24시간 동안 10% FBS 배지로 배양한 후, FBS를 함유하지 않은 배지로 각 시료들의 최종농도가 1, 10, 50, 100 및 200㎍/㎖ 농도로 조제하여 세포에 처리한 후 24시간 동안 배양하였다.HaCaT cells were dispensed at 1x10 4 / well in a 96 well plate and incubated with 10% FBS medium for 24 hours, and the final concentration of each sample was 1, 10, 50, 100 and 200 μg / Prepared at a concentration of ㎖, treated with cells, and cultured for 24 hours.

세포독성의 확인을 위해 Cell Titer 96 Aqueous One solution cell proliferation assay kit(Promega, WI, USA)를 이용하여 microplate reader(Molecular Devices, VersaMax ELISA Microplate Reader, USA)로 490nm에서 흡광도를 측정하였으며 그 결과를 아래 [표 2]로 나타내었다.To confirm cytotoxicity, absorbance was measured at 490 nm with a microplate reader (Molecular Devices, VersaMax ELISA Microplate Reader, USA) using the Cell Titer 96 Aqueous One solution cell proliferation assay kit (Promega, WI, USA). It is shown in Table 2.

시료명 (㎍/㎖)Sample name (µg / ml) Cell Viability (%)Cell Viability (%) Control 군Control group 100±5.2100 ± 5.2 도라지 에탄올 추출물Bellflower ethanol extract 1One 120.9±7.3* 120.9 ± 7.3 * 1010 117.4±6.7* 117.4 ± 6.7 * 5050 118.2±7.8* 118.2 ± 7.8 * 100100 110.3±3.4* 110.3 ± 3.4 * 200200 93.9±4.693.9 ± 4.6 * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 2]에 나타난 바와같이 1, 10, 50, 100, 200㎍/㎖ 농도에서 도라지 에탄올 추출물의 독성은 없었다.As shown in [Table 2], there was no toxicity of the bellflower ethanol extract at concentrations of 1, 10, 50, 100, and 200 μg / ml.

3). 피부세포 재생효과 평가 3). Evaluation of skin cell regeneration effect

HaCaT 세포주를 2×103 cells/㎖의 농도로 96 well plate에 분주하고, 24시간 동안 37℃, 습도 95%, CO2 5%로 조절된 CO2 배양기에서 배양하였다. 새로운 배지에 각 시료를 농도 1, 10, 50, 100, 200㎍/㎖ 범위 내에서 적절한 농도에 맞춰 세포에 처리한 후 1일 및 2일 동안 배양하였다. 세포주의 생존율을 측정하기 위해 Cell Counting Kit-8 (CCK-8, Dojindo Mol. Tech., Rockville., MD, USA)를 이용하여 microplate reader (Molecular Devices, VersaMax ELISA Microplate Reader, USA)로 450nm에서 흡광도를 측정하였다. 세포의 재생효과는 시료를 처리하지 않은 대조군에 대비한 시료 처리군의 흡광도로 표시하였으며, 그 결과를 아래 [표 3] 및 [도 2]으로 나타내었다.The HaCaT cell line was dispensed into a 96 well plate at a concentration of 2 × 10 3 cells / ml, and cultured in a CO 2 incubator controlled at 37 ° C., 95% humidity, and 5% CO 2 for 24 hours. Each sample was treated with cells at appropriate concentrations within a range of concentrations of 1, 10, 50, 100, and 200 μg / ml in fresh medium, and then cultured for 1 and 2 days. Absorbance at 450 nm with a microplate reader (Molecular Devices, VersaMax ELISA Microplate Reader, USA) using Cell Counting Kit-8 (CCK-8, Dojindo Mol. Tech., Rockville., MD, USA) to measure cell line viability. Was measured. The regeneration effect of the cells was expressed as the absorbance of the sample treatment group compared to the control group that did not process the sample, and the results are shown in [Table 3] and [Figure 2] below.

시료명(㎍/㎖)Sample name (µg / ml) 세포증식률(%)Cell proliferation rate (%) 1일1 day 2일2 days Control 군Control group 100.0±1.8100.0 ± 1.8 100.0±6.3100.0 ± 6.3 도라지 에탄올 추출물Bellflower ethanol extract 1One 108.0±2.4* 108.0 ± 2.4 * 113.8±11.6113.8 ± 11.6 1010 113.2±5.7* 113.2 ± 5.7 * 131.2±4.2* 131.2 ± 4.2 * 5050 113.0±2.6* 113.0 ± 2.6 * 125.8±7.4* 125.8 ± 7.4 * 100100 116.8±2.8* 116.8 ± 2.8 * 127.6±7.2* 127.6 ± 7.2 * 200200 113.5±3.3* 113.5 ± 3.3 * 143.7±16.9* 143.7 ± 16.9 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 3]에 타난 바와 같이 1일 배양 시는 대조군과 대비 16.8% 증가하였고, 2일 배양시는 50, 100㎍/㎖ 에서는 25.8, 27.6% 증가하였고 200㎍/㎖에서는 43.7%가 증가하여 농도 의존적인 증식활성을 확인할 수 있었다.As shown in [Table 3], the 1-day incubation increased by 16.8% compared to the control group, the 2-day incubation increased by 25.8, 27.6% at 50, 100 μg / mL, and increased by 43.7% at 200 μg / mL. The concentration-dependent proliferative activity was confirmed.

<시험예 3> 항염증 효능 시험<Test Example 3> anti-inflammatory efficacy test

1). 세포의 배양 One). Cell culture

실험에 사용한 세포주 RAW264.7은 한국세포주은행(KCLB, Seoul, Korea)에서 분양받아 사용하였다. 각 세포주를 10㎝ well plate에서 배양하여 1주일에 2 ~ 3회 계대하였으며, 배지는 10% Fetal Bovine Serum(FBS, Lonza, Valais, Switzerland) medium을 함유한 성장배지를 이용하였다. 세포주는 습도 95%, 5% CO2, 37℃로 조절된 배양기에서 배양하였으며, 배지는 2일에 한번 씩 교환하였다. 이때 미생물의 오염이나 증식을 억제하기 위해 배지용 항생제(Penicillin streptomycin, Gibco, CA, USA)를 사용하였다. 세포가 80% 정도 dish를 덮으면 phosphated-buffered saline-EDTA(PBS-EDTA)로 세척한 후 트립신 처리하여 계대 배양하였으며, 배지는 48시간마다 교환하여 세포를 배양하였다.The cell line RAW264.7 used in the experiment was used for pre-sale from the Korea Cell Line Bank (KCLB, Seoul, Korea). Each cell line was cultured in a 10 cm well plate and passaged 2-3 times a week, and the medium was a growth medium containing 10% Fetal Bovine Serum (FBS, Lonza, Valais, Switzerland) medium. Cell lines were cultured in an incubator controlled at 95% humidity, 5% CO 2 , and 37 ° C, and the medium was changed once every 2 days. At this time, a medium antibiotic (Penicillin streptomycin, Gibco, CA, USA) was used to suppress contamination or proliferation of microorganisms. When the cells were covered with 80% of the dish, they were washed with phosphated-buffered saline-EDTA (PBS-EDTA), followed by trypsin treatment, and the cells were cultured by changing the medium every 48 hours.

2). Nitric Oxide 생성량 측정 2). Nitric Oxide production measurement

RAW 264.7 세포주를 96 well에 분주한 후 세포가 바닥의 약80% 이상 자랄 때까지 배양하였다. 염증을 유발하기 위하여 lipopolysaccharide (LPS, Sigma-Aldrich, MO, USA)를 1 ㎍/㎖의 농도로 처리하였다.  The RAW 264.7 cell line was dispensed into 96 wells, and then cultured until the cells grew to about 80% or more of the bottom. To induce inflammation, lipopolysaccharide (LPS, Sigma-Aldrich, MO, USA) was treated at a concentration of 1 μg / ml.

시료 및 대비를 위해 감초추출물의 항염증 효능을 확인하기 위해 LPS와 함께 시료 및 감초추출물의 농도가 1, 10, 50, 100, 200 ㎍/㎖가 되도록 세포에 배지에 녹여 24시간 동안 배양하고, NO 생성량은 Griess 시약을 사용하여 측정하였다. Griess 시약은 2.5%의 phosphate 용액에 1% sulfanilamide와 0.1% naphthylethylene-diamine dihydrochloride를 혼합하여 만들었다. 상기 배양한 세포의 상등액 50㎕를 96 well plate에 취하고 여기에 Griess 시약 50㎕를 가해 15분 동안 실온에서 반응시킨 후 microplate reader(Molecular Devices, VersaMax ELISA Microplate Reader, USA)를 이용하여 540㎚에서 흡광도를 측정하였다. 항염증 효능의 측정은 대식세포주에 LPS를 처리하여 LPS만을 처리한 군의 NO 생성량에 대한 LPS 와 함께 시료 및 감초출물을 처리한 군의 NO 생성량을 측정하여 시료가 NO 생성 저해 효능을 가지는 지를 측정하였으며, 그 결과를 아래 [표 4] 및 [도 4]로 나타내었다.To check the anti-inflammatory efficacy of the licorice extract for sample and contrast, dissolve in the medium in the cells and incubate for 24 hours so that the concentration of the sample and licorice extract is 1, 10, 50, 100, 200 μg / ml with LPS, NO production was measured using Griess reagent. Griess reagent was made by mixing 1% sulfanilamide and 0.1% naphthylethylene-diamine dihydrochloride in 2.5% phosphate solution. 50 μl of the supernatant of the cultured cells was added to a 96 well plate, 50 μl of Griess reagent was added thereto, and the mixture was reacted at room temperature for 15 minutes, and absorbance at 540 nm using a microplate reader (Molecular Devices, VersaMax ELISA Microplate Reader, USA). Was measured. Measurement of anti-inflammatory efficacy is measured by measuring the amount of NO produced in the sample and licorice extract-treated groups along with LPS for the amount of NO produced in the group treated with LPS only by treating LPS in a macrophage cell line to determine whether the sample has an effect of inhibiting NO production. The results are shown in [Table 4] and [Figure 4] below.

시료명(㎍/㎖)Sample name (µg / ml) NO 생성량(%)NO production (%) 대조군Control 11.6±0.211.6 ± 0.2 대조군(+ LPS)Control (+ LPS) 100.0±1.2100.0 ± 1.2 도라지 에탄올 추출물Bellflower ethanol extract +LPS+ LPS 1One 81.3 ±8.1* 81.3 ± 8.1 * 1010 67.0 ±4.4* 67.0 ± 4.4 * 100100 67.2 ±4.9* 67.2 ± 4.9 * 200200 65.7 ±5.0* 65.7 ± 5.0 * 감초 추출물Licorice extract 1010 79.8 ±4.2* 79.8 ± 4.2 * 5050 68.9±3.9* 68.9 ± 3.9 * 100100 57.6±5.6* 57.6 ± 5.6 * 200200 46.3±5.9* 46.3 ± 5.9 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 4]에 나타난 바와 같이 도라지 에탄올 추출물 10㎍/㎖에서는 LPS 만을 처리한 대조군에 대비하여 33%의 생성 저해능을 확인하였고, 200㎍/㎖의 농도에서는 34.3%의 생성저해능을 보여주었다. 항염증 활성이 높은 감초 추출물은 10㎍/㎖의 농도에서 19.2%의 생성 저해능을, 200㎍/㎖의 농도에서는 53.7%의 높은 생성 저해능을 나타내었다. 도라지 에탄올 추출물은 감초추출물에 비해 저농도에서는 더 높은 활성을 보여주는 것이다.As shown in [Table 4], 10 μg / mL of bellflower ethanol extract showed 33% inhibition of production compared to the control group treated with LPS only, and showed a 34.3% inhibitory capacity at concentration of 200 μg / mL. The licorice extract with high anti-inflammatory activity showed a production inhibitory ability of 19.2% at a concentration of 10 µg / ml and a high production inhibitory ability of 53.7% at a concentration of 200 µg / ml. The bellflower ethanol extract shows higher activity at lower concentrations than licorice extract.

3). PGE2 생성량 측정3). PGE 2 production measurement

PGE2의 측정은 Prostaglandin E2 EIA Kit를 Cayman Chemical Company(Ann Arbor, Michigan, USA)에서 구매하여 사용하였으며, 측정방법은 제조회사의 분석방법에 따라 정량하였다. 즉, RAW 264.7 세포에 시료 및 감초출물을 LPS와 함께 0.01, 0.1, 1, 10, 50, 100, 200㎍/㎖ 농도로 24시간 전처리 후 세포 배양 상층액을 PGE2 측정에 사용하였는데, 배양액을 goat anti-mouse로 coating된 96well plate에 각각 배양액을 50㎕씩 loading 하였다. 여기에 primary antibody solution 50㎕와 PGE2 conjugate 50㎕씩 첨가하여 4℃에서 18시간 동안 반응시킨 후, Washing buffer로 5회 세척 한 후 Ellman's reagent을 200 ㎕씩 처리하여 60 ~ 90분간 교반하면서 반응 시킨 후, 405 ~ 420 nm에서 흡광도를 측정하였으며, 그 결과를 아래 [표 5] 및 [도 3]으로 나타내었다.Measurement of PGE 2 was used by purchasing the Prostaglandin E2 EIA Kit from Cayman Chemical Company (Ann Arbor, Michigan, USA), and the measurement method was quantified according to the manufacturer's analysis method. That is, RAW 264.7 cells were sampled and licorice extract together with LPS at a concentration of 0.01, 0.1, 1, 10, 50, 100, 200 μg / ml for 24 hours, and the cell culture supernatant was used for PGE 2 measurement. 50 μl of each culture was loaded onto 96-well plates coated with goat anti-mouse. Here, 50 µl of primary antibody solution and 50 µl of PGE 2 conjugate were added to react for 18 hours at 4 ° C., washed 5 times with Washing buffer, and then treated with 200 µl of Ellman's reagent and reacted with stirring for 60 to 90 minutes. Then, absorbance was measured at 405 to 420 nm, and the results are shown in [Table 5] and [Figure 3] below.

시료명(㎍/㎖)Sample name (µg / ml) Prostaglandin EProstaglandin E 22 생성량(%) Production amount (%) 대조군Control 34.6±1.834.6 ± 1.8 대조군(+ LPS)Control (+ LPS) 100.0±5.0100.0 ± 5.0 도라지 에탄올 추출물Bellflower ethanol extract +LPS+ LPS 1One 81.8±0.8* 81.8 ± 0.8 * 1010 88.8±4.5* 88.8 ± 4.5 * 100100 61.5±3.9* 61.5 ± 3.9 * 200200 59.4±1.2* 59.4 ± 1.2 * 감초 추출물Licorice extract 5050 84.3±2.1* 84.3 ± 2.1 * 100100 67.2±1.4* 67.2 ± 1.4 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 5]에 나타난 바와 같이 도라지 에탄올 추출물은 LPS처리군과 비교하여 PGE2 생성량이 1, 10㎍/㎖ 농도에서 18.2%, 11.2% 감소하였고, 200㎍/㎖에서는 40.6% 감소하였다. 감초 추출물 50㎍/㎖에서는 15.7%, 100㎍/㎖의 농도에서는 32.8% 저해되었다. PGE2 생성 저해능은 감초추출물보다 더 높은 활성을 보여주었으며, 이러한 결괴는 도라지 에탄올 추출물은 NO 생성 저해능과 PGE2 저해 활성이 매우 높고, 감초 추출물과 비교하여도 더 높은 활성이 있음을 확인할 수 있다.As shown in [Table 5], the amount of PGE 2 produced in the bellflower ethanol extract was decreased by 18.2% and 11.2% at concentrations of 1 and 10 µg / ml compared to the LPS-treated group, and decreased by 40.6% at 200 µg / ml. Licorice extract was inhibited at 15.7% at 50µg / ml and 32.8% at a concentration of 100µg / ml. Inhibition of PGE 2 production showed higher activity than licorice extract, and it was confirmed that the ethanol extract of bellflower ethanol extract had very high NO production inhibitory activity and PGE 2 inhibitory activity, and had higher activity compared to licorice extract.

<시험예 4> 모유두세포에 대한 증식효능 시험<Test Example 4> Proliferation efficacy test for dermal papilla cells

모유두세포(HFDPC)는 모낭을 구성하고 있으며, 모유두세포의 증식 및 분화는 모발성장 주기의 진행과 모발형성에 일차적으로 관여하는 것이 많은 연구를 통해 밝혀졌다. 활발히 모발이 성장하는 성장기에는 모유두세포의 활발한 증식 및 분화가 활발하게 일어나며 모발의 성장이 중단되며 탈모현상이 일어나는 퇴행기, 휴지기, 탈모기에는 이 세포가 사멸된다. 따라서 모유두세포의 증식을 측정하여 도라지 에탄올 추출물의 탈모방지효과를 시험하였다. Hair papilla cells (HFDPC) constitute hair follicles, and many studies have shown that proliferation and differentiation of hair papilla cells are primarily involved in the progression of hair growth cycle and hair formation. Active growth and differentiation of hair papillae occurs actively during the growth phase when hair is actively growing, hair growth is stopped, and these cells are killed during the degenerative, resting, and alopecia phases when hair loss occurs. Therefore, the proliferation of dermal papilla cells was measured to test the anti-hair loss effect of the bellflower ethanol extract.

1). 세포독성시험  One). Cytotoxicity test

세포 독성은 모유두 세포인 HDFPC cell로 확인하였다. 즉, 세포 배양용 플라스크에 배양한 HDFPC 세포주를 10㎖ 피펫으로 세포를 플라스크에서 떼어내어 계대하였고, 세포는 10% FBS가 함유된 folicle dermal papilla cell growth medium로 배양하였다. HDFPC 세포주를 1×104 cells/well의 농도로 96 well plate에 분주하고, 24시간 동안 37℃, 습도 95%, CO2 5%로 조절된 CO2 배양기에서 배양하였다. 새로운 배지에 시료를 최종 농도가 1, 10, 50, 100, 200㎍/㎖이 되도록 녹여 세포주에 처리한 후 24시간 동안 배양하였다. 세포주의 생존률을 측정하기 위해 MTS시약을 이용하여 microplate reader(Molecular Devices, VersaMax ELISA Microplate Reader, USA)로 490 nm에서 흡광도를 측정하였으며, 도라지 에탄올 추출물을 처리했을 때 모유두세포에 독성이 나타나는지 확인하기 위해 모유두세포를 5x103/well로 분주한 다음 24시간이 지나서 도라지 에탄올 추출물을 아래 [표 6]과 같은 농도로 처리한 후 세포의 독성을 확인하였다. 세포의 생존율은 시료를 처리하지 않은 대조군에 대비한 시료 처리군의 흡광도로 표시하였으며 그 결과를 아래 [표 6]으로 나타내었다.Cytotoxicity was confirmed by HDFPC cell, a papillary cell. That is, the HDFPC cell line cultured in the cell culture flask was passaged by removing the cells from the flask with a 10 ml pipette, and the cells were cultured with folicle dermal papilla cell growth medium containing 10% FBS. The HDFPC cell line was dispensed into a 96 well plate at a concentration of 1 × 10 4 cells / well, and cultured in a CO 2 incubator adjusted to 37 ° C., humidity 95%, and CO 2 5% for 24 hours. Samples were dissolved in fresh medium so that the final concentrations were 1, 10, 50, 100, and 200 µg / ml, treated with cell lines, and cultured for 24 hours. To measure the viability of the cell line, absorbance was measured at 490 nm using a microplate reader (Molecular Devices, VersaMax ELISA Microplate Reader, USA) using MTS reagent, and to confirm that toxicity was seen in papillary cells when treated with bellflower ethanol extract. After dividing the dermal papilla cells into 5x10 3 / well, after 24 hours, the bellflower ethanol extract was treated with the concentration as shown in [Table 6] to confirm the toxicity of the cells. The survival rate of the cells was expressed as the absorbance of the sample treatment group compared to the control group not treated with the sample, and the results are shown in [Table 6] below.

시료명 (㎍/㎖)Sample name (µg / ml) Cell Viability (%)Cell Viability (%) Control 군Control group 100.0±0.0100.0 ± 0.0 도라지 에탄올 추출물Bellflower ethanol extract 1One 108.3±3.3108.3 ± 3.3 1010 109.0±3.1109.0 ± 3.1 5050 101.7±3.0101.7 ± 3.0 100100 101.9±3.7101.9 ± 3.7 200200 85.2±1.4* 85.2 ± 1.4 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 6]에 나타난 바와 같이 도라지 에탄올 추출물의 200㎍/㎖ 농도에서 독성이 확인되었다.As shown in [Table 6], toxicity was confirmed at a concentration of 200 μg / ml of the bellflower ethanol extract.

2). 세포 재생 효능 시험  2). Cell regeneration efficacy test

상기 확인한 모유두세포 독성시험결과를 토대로 도라지 에탄올 추출물 1 ~ 100㎍/㎖까지의 농도로 모유두세포에 처리한 다음 3일까지 증식과정을 살펴보았다. 그 결과 아래 [표 7]에 나타난 바와같이 1일차는 200㎍/㎖에서 124.8%의 높은 증식을 보여주었고, 농도 의존적 증식하는 경향을 나타냈지만, 2일차부터는 증식효과가 이어지지 못하고 3일차에서는 증식률이 감소하였다.  Based on the confirmed results of the papilloma cell toxicity test, treatment was performed on the papillary cells at a concentration of 1-100 μg / ml of bellflower ethanol extract, and then the proliferation process was examined until 3 days. As a result, as shown in [Table 7] below, Day 1 showed a high proliferation of 124.8% at 200 μg / ml, and showed a tendency to increase concentration-dependently. Decreased.

시료명(㎍/㎖)Sample name (µg / ml) 세포증식률(%)Cell proliferation rate (%) 1일1 day 2일2 days 3일3 days Control 군Control group 100.0±2.4100.0 ± 2.4 100.0±6.2100.0 ± 6.2 100.0±6.0100.0 ± 6.0 도라지 에탄올 추출물Bellflower ethanol extract 1One 100.3±3.0100.3 ± 3.0 95.6±1.295.6 ± 1.2 107.4±2.8107.4 ± 2.8 1010 117.6±7.0* 117.6 ± 7.0 * 104.1±1.3104.1 ± 1.3 106.8±2.4106.8 ± 2.4 100100 122.6±6.0* 122.6 ± 6.0 * 98.9±3.498.9 ± 3.4 102.8±2.8102.8 ± 2.8 200200 124.8±6.1* 124.8 ± 6.1 * 96.4±3.396.4 ± 3.3 88.3±5.3* 88.3 ± 5.3 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

<시험예 5> Dihydrotestosterone 생성 저해활성 시험<Test Example 5> Dihydrotestosterone production inhibitory activity test

탈모의 원인이 된다고 알려진 Dihydrotestosterone의 생성 저해능을 측정하여 개발 원료의 탈모 예방 효능을 측정해 보았다. 시험에 사용된 시료의 처리는 Rat의 간의 중량 2배에 해당하는 PBS를 첨가 후 간을 균질화하였다. 균질화된 간 0.5㎖에 시험액 50㎕를 첨가한 후 37℃에서 30분간 교반하며 반응시켰다. 반응완료 후 extraction buffer(50mM Na2HPO4, 0.25 M sucrose)를 0.5㎖ 첨가한 후 4℃, 1,500g에서 20분간 원심하여 상등액을 취하여 Dihydrotestosterone(DHT) kit를 진행하였다. DHT kit는 Immuno-Biological Laboratories, Inc.사의 IB59116 제품을 사용하였으며 그 결과를 아래 [표 8] 및 [도 5]에 나타내었다.By measuring the ability to inhibit the production of Dihydrotestosterone, which is known to cause hair loss, the efficacy of preventing the hair loss of the developed ingredients was measured. In the treatment of the sample used in the test, the liver was homogenized after PBS corresponding to twice the weight of the rat was added. After adding 50 μl of the test solution to 0.5 ml of homogenized liver, the mixture was reacted with stirring at 37 ° C. for 30 minutes. After completion of the reaction, 0.5 ml of extraction buffer (50 mM Na 2 HPO 4, 0.25 M sucrose) was added and centrifuged at 4 ° C. and 1,500 g for 20 minutes to take a supernatant and proceed with a Dihydrotestosterone (DHT) kit. The DHT kit used IB59116 manufactured by Immuno-Biological Laboratories, Inc., and the results are shown in [Table 8] and [FIG. 5] below.

시료명(㎍/㎖)Sample name (µg / ml) Dihydrotestosterone(%)Dihydrotestosterone (%) ControlControl 100.0±5.4100.0 ± 5.4 도라지 에탄올 추출물Bellflower ethanol extract 1One 78.3±6.7* 78.3 ± 6.7 * 1010 64.5±7.3* 64.5 ± 7.3 * 5050 76.8±11.176.8 ± 11.1 100100 76.5±14.076.5 ± 14.0 FinasterideFinasteride 1One 100.0±0.9100.0 ± 0.9 1010 68.5±2.5* 68.5 ± 2.5 * 100100 48.5±2.8* 48.5 ± 2.8 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 8]에 나타난 바와 같이 도라지 에탄올 추출물은 미첨가 대조군에 비해 100㎍/㎖의 농도에서 23.5% 저해활성을 보여주었고, DHT생성을 저해하는 것으로 알려진 Finasteride는 10㎍/㎖의 농도에서 31.5%의 높은 활성 저해능을 확인하였다. As shown in [Table 8], the bellflower ethanol extract showed 23.5% inhibitory activity at a concentration of 100 μg / ml compared to the non-added control group, and Finasteride known to inhibit DHT production was 31.5 at a concentration of 10 μg / ml. % High activity inhibitory activity was confirmed.

상기한 <시험예 1> 내지 <시험예 5>를 통하여 본 발명에 따른 도라지 에탄올 추출물의 탈모예방 및 개선 효과를 확인할 수 있었다.Through the above <Test Example 1> to <Test Example 5> it was confirmed the hair loss prevention and improvement effect of the bellflower ethanol extract according to the present invention.

아래에서는 도라지 에탄올 추출물의 탈모예방 효능을 갖는 물질을 확인하기 위하여 상기 <실시예 2>에서 수득한 분획물 즉, 도라지 크로로포름 분획물, 도라지 에틸아세테이트 분획물, 도라지 부탄올 분획물, 도라지 물 분획물을 시료로 하여 상기한 <시험예 1> 내지 <시험예 5>의 시험방법과 동일한 방법으로 탈모예방 효과를 시험하였다.Below, in order to identify a substance having a hair loss prevention effect of a bellflower ethanol extract, the fraction obtained in Example 2 above, that is, a bellflower croroform fraction, a bellflower ethyl acetate fraction, a bellflower butanol fraction, and a bellflower water fraction as a sample The hair loss prevention effect was tested in the same manner as the test methods of <Test Example 1> to <Test Example 5>.

B. B. 도라지 분획물의 탈모예방 및 발모개선 효능 시험Prevention of hair loss and efficacy for improving hair growth of bellflower fraction

<시험예 6> 도라지 분획물들의 항산화능 시험<Test Example 6> Antioxidant activity test of bellflower fractions

도라지 분획물들의 항산화 활성을 확인하기 위하여 상기 <시험예 1>과 동일한 방법으로 DPPH 소거능와 ABTS Radical 소거능을 측정하고 그 결과를 아래 [표 9] 및 [표 10]으로 각각 나타내었으며, [도 6]으로 첨부하였다. In order to confirm the antioxidant activity of bellflower fractions, DPPH scavenging ability and ABTS Radical scavenging ability were measured in the same manner as in <Test Example 1>, and the results are shown in [Table 9] and [Table 10], respectively. Attached.


시료농도Sample concentration
(mg/㎖)(mg / ml)
시료명 (%)Sample name (%)
도라지 클로로포름Bellflower chloroform
분획Fraction
도라지 에틸아세테이트 분획Bellflower ethyl acetate fraction 도라지 Bellflower
부탄올 분획Butanol fraction
도라지 Bellflower
물 분획Water fraction
1One 17.0 17.0 ±± 3.03.0 11.5 11.5 ±± 3.63.6 0.0 0.0 ±± 2.32.3 5.1 5.1 ±± 0.60.6 1010 50.7 50.7 ±± 7.37.3 48.0 48.0 ±± 1.41.4 40.9 40.9 ±± 4.14.1 8.9 8.9 ±± 1.51.5 5050 85.4 85.4 ±± 6.66.6 77.2 77.2 ±± 3.53.5 78.3 78.3 ±± 3.23.2 26.826.8 ±± 3.13.1 100100 89.2 89.2 ±± 4.34.3 94.4 94.4 ±± 2.72.7 89.8 89.8 ±± 1.01.0 41.2 41.2 ±± 2.42.4 200200 96.9 96.9 ±± 2.72.7 96.8 96.8 ±± 2.22.2 93.0 93.0 ±± 0.30.3 51.951.9 ±± 3.93.9 * IC50 : 도라지 클로로포름 분획물 19.5mg/㎖, 도라지 에틸아세테이트 분획물 29.6mg/㎖, 도라지 부탄올 분획물 16.2mg/㎖, 도라지 물층 분획물 121.8mg/㎖* IC 50 : bellflower chloroform fraction 19.5mg / mL, bellflower ethyl acetate fraction 29.6mg / mL, bellflower butanol fraction 16.2mg / mL, bellflower water layer fraction 121.8mg / mL


시료농도Sample concentration
(mg/㎖)(mg / ml)
시료명 (%)Sample name (%)
도라지 클로로포름Bellflower chloroform
분획Fraction
도라지 에틸아세테이트 분획Bellflower ethyl acetate fraction 도라지 Bellflower
부탄올 분획Butanol fraction
도라지 Bellflower
물 분획Water fraction
1One 32.0 32.0 ±± 91.391.3 27.2 27.2 ±± 0.70.7 19.5 19.5 ±± 2.32.3 7.87.8 ±± 1.21.2 1010 91.3 91.3 ±± 3.33.3 91.1 91.1 ±± 2.52.5 90.0 90.0 ±± 3.93.9 27.2 27.2 ±± 1.31.3 5050 100.0 100.0 ±± 6.06.0 100.0 100.0 ±± 3.33.3 100.0 100.0 ±± 0.50.5 67.8 67.8 ±± 2.32.3 100100 97.6 97.6 ±± 7.77.7 96.6 96.6 ±± 5.65.6 100.0 100.0 ±± 3.63.6 98.798.7 ±± 1.41.4 200200 95.3 95.3 ±± 11.511.5 84.0 84.0 ±± 5.95.9 93.4 93.4 ±± 10.010.0 99.9 99.9 ±± 0.20.2 * IC50 : 도라지 클로로포름 분획물 3.7 mg/㎖, 도라지 에틸아세테이트 분획물 4.2mg/㎖, 도라지 부탄올 분획물 4.9mg/㎖, 도라지 물층 분획물 39.8mg/㎖* IC 50 : bellflower chloroform fraction 3.7 mg / ml, bellflower ethyl acetate fraction 4.2mg / ml, bellflower butanol fraction 4.9mg / ml, bellflower water layer fraction 39.8mg / ml

상기 [표 9] 및 [표 10]에 나타난 바와 같이 도라지 물 분획물을 제외하고 나머지 분획물들은 원액에 가까울수록 뛰어난 DPPH 소거 효과를 나타내었다. 그 중에서도 특히 부탄올 분획물은 다른 분획물들 보다 낮은 농도(16.2mg/㎖)에서도 50% 이상 소거능을 나타내 4가지 분획물 중에서 가장 뛰어난 효과를 나타내었으며, IC50 값을 비교해보면 도라지 부탄올 분획물 다음으로는 도라지 클로로포름, 에틸아세테이트 분획물 순으로 항산화 효과가 뛰어났다. As shown in [Table 9] and [Table 10], except for the bellflower water fraction, the remaining fractions showed superior DPPH scavenging effect as they were closer to the stock solution. Among them, the butanol fraction showed 50% or more scavenging ability at a lower concentration than other fractions (16.2 mg / ml), showing the most excellent effect among the four fractions.When comparing the IC 50 values, the bellflower butanol fraction was followed by the bellflower chloroform , Ethyl acetate fractions were excellent in antioxidant effect.

ABTS 소거능 역시 마찬가지로 원액에 가까울수록 모든 분획물들의 라디칼 소거능이 뛰어났다. IC50값을 비교한 결과 그 중에서도 낮은 농도에서도 높은 활성을 나타내는 도라지 클로로포름, 에틸아세테이트 분획물이 가장 뛰어난 효과를 나타내었다. IC50값으로 DPPH와 ABTS 활성을 비교한 결과 모든 분획물들에서 DPPH 라디칼 소거능보다 ABTS 라디칼 소거능이 훨씬 뛰어난 것을 확인하였다.Likewise, the ABTS scavenging ability was closer to the stock solution, and the radical scavenging ability of all fractions was superior. As a result of comparing the IC 50 values, the bellflower chloroform and ethyl acetate fractions exhibiting the highest activity even at low concentrations showed the most excellent effect. As a result of comparing DPPH and ABTS activity with IC 50 value, it was confirmed that ABTS radical scavenging ability was much superior to DPPH radical scavenging ability in all fractions.

<시험예 7> 도라지 분획물들의 피부세포 독성 및 재생효과 시험<Test Example 7> Skin cell toxicity and regenerative effect test of bellflower fractions

1). 피부세포 독성 시험 One). Skin cell toxicity test

<시험예 2>와 동일한 방법으로 도라지 분획물들의 피부세포독성을 시험하였으며 세포독성시험에서 50㎍/㎖ 이상 고농도에서는 독성이 나타나 최소 0.001 ~ 10㎍/㎖ 농도로 설정하여 재실험한 결과 독성이 나타나지 않았으며 그 결과를 아래 [표 11]로 각각 나타내고, [도 7]로 첨부하였다.  In the same manner as in <Test Example 2>, the skin cytotoxicity of the bellflower fractions was tested. In the cytotoxicity test, toxicity was observed at a high concentration of 50 μg / ml or more, and the toxicity was shown as a result of retesting with a minimum concentration of 0.001 to 10 μg / ml. The results are shown in Table 11 below and attached as [FIG. 7].

시료명 (㎍/ml) Sample name (㎍ / ml) Cell Viability (%)Cell Viability (%) Control 군Control group 100 100 ±± 5.25.2 클로로포름 분획물Chloroform fraction 0.001 0.001 117.7117.7 ±± 4.9* 4.9 * 0.005 0.005 109.3109.3 ±± 7.97.9 0.01 0.01 114.7114.7 ±± 10.3* 10.3 * 0.1 0.1 102.2102.2 ±± 1.11.1 에틸아세테이트 분획물Ethyl acetate fraction 0.010.01 101.9101.9 ±± 13.913.9 0.10.1 110.0110.0 ±± 4.1* 4.1 * 1 One 107.3107.3 ±± 3.7* 3.7 * 10 10 104.7104.7 ±± 2.3* 2.3 * 부탄올 분획물Butanol fraction 0.0050.005 101.2101.2 ±± 7.87.8 0.010.01 100.9100.9 ±± 12.912.9 0.10.1 107.8107.8 ±± 2.6* 2.6 * 1One 107.5107.5 ±± 1.8* 1.8 * 물 분획물Water fraction 0.0050.005 114.7114.7 ±± 5.1* 5.1 * 0.010.01 101.8101.8 ±± 1.21.2 0.1 0.1 103.4103.4 ±± 7.57.5 1 One 98.698.6 ±± 2.32.3 * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

2). 피부세포 재생효과 시험 2). Skin cell regeneration effect test

상기 확인한 <시험예 7> 독성시험결과를 토대로 하여 도라지 분획물들의 피부세포재생효과를 시험하였으며 그 결과를 아래 [표 12] 및 [도 8]로 나타내었다.  Based on the confirmed <Test Example 7> toxicity test results, the skin cell regeneration effect of bellflower fractions was tested and the results are shown in [Table 12] and [Figure 8] below.

시료명 (㎍/ml) Sample name (㎍ / ml) 세포증식률 (%)Cell proliferation rate (%) 1일1 day 2일2 days Control 군Control group 도라지 클로로포름 분획물Bellflower chloroform fraction 0.0010.001 115.7 115.7 ±± 3.5* 3.5 * 108.2 108.2 ±± 2.12.1 0.0050.005 117.9 117.9 ±± 1.9* 1.9 * 115.6 115.6 ±± 8.6* 8.6 * 0.01 0.01 120.4 120.4 ±± 4.0* 4.0 * 105.6 105.6 ±± 4.04.0 0.1 0.1 115.1 115.1 ±± 2.6* 2.6 * 105.3 105.3 ±± 2.12.1 도라지 에틸아세테이트Bellflower ethyl acetate
분획물Fraction
0.010.01 110.7110.7 ±± 5.7* 5.7 * 107.8 107.8 ±± 9.49.4
0.10.1 110.0 110.0 ±± 2.7* 2.7 * 116.5 116.5 ±± 6.6* 6.6 * 1 One 108.5 108.5 ±± 5.4* 5.4 * 106.6 106.6 ±± 9.69.6 1010 108.5 108.5 ±± 4.6* 4.6 * 106.9 106.9 ±± 3.93.9 도라지 부탄올 분획물Bellflower butanol fraction 0.0050.005 113.6 113.6 ±± 3.2* 3.2 * 110.0 110.0 ±± 6.26.2 0.010.01 121.1121.1 ±± 3.7* 3.7 * 110.6 110.6 ±± 2.22.2 0.10.1 125.7 125.7 ±± 10.2* 10.2 * 108.0 108.0 ±± 2.32.3 1One 131.4 131.4 ±± 8.1* 8.1 * 112.5 112.5 ±± 7.37.3 도라지 물 분획물Bellflower water fraction 0.0050.005 110.8110.8 ±± 3.8* 3.8 * 109.0 109.0 ±± 8.68.6 0.010.01 119.3 119.3 ±± 3.6* 3.6 * 108.4 108.4 ±± 3.93.9 0.10.1 116.2 116.2 ±± 3.9* 3.9 * 113.6 113.6 ±± 5.7* 5.7 * 1One 118.6 118.6 ±± 9.3* 9.3 * 106.7 106.7 ±± 5.45.4 * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 12]에 나타난 바와같이 모든 분획물에서 피부세포 재생 효능이 있었으며. 특히 부탄올 분획물은 1일 배양 시 0.1㎍/㎖의 농도에서는 25.7%의 증식효능을, 1㎍/㎖의 농도에서 31.4의 높은 증식능을 확인하였다. 클로로포름, 물 분획물도 20%에 가까운 증식률을 나타냈지만 2일차부터는 모든 분획물에서 1일차에 비해 증식률이 감소하였다. 피부세포 재생효능에서는 부탄올 분획물에서 가장 높은 활성을 확인할 수 있었다.As shown in [Table 12], all fractions had skin cell regeneration efficacy. In particular, the butanol fraction was found to have a proliferation efficiency of 25.7% at a concentration of 0.1 µg / ml and a high proliferation capacity of 31.4 at a concentration of 1 µg / ml. Chloroform and water fractions also showed proliferation rates close to 20%, but from day 2, proliferation rates decreased in all fractions compared to day 1. In the skin cell regeneration efficacy, the highest activity was found in the butanol fraction.

<시험예 8> 도라지 분획물들의 항염증 효능 시험<Test Example 8> Anti-inflammatory efficacy test of bellflower fractions

1). NO 생성 저해활성 시험 One). NO production inhibitory activity test

상기 <시험예 3> 과 동일한 방법으로 도라지 분획물들의 NO 생성 저해활성 시험은 독성이 나타나지 않는 농도에서 실시하였으며, 결과를 아래 [표 13]으로 나타내었다.  In the same manner as in <Test Example 3>, the NO production inhibitory activity test of bellflower fractions was carried out at a concentration at which no toxicity appeared, and the results are shown in [Table 13] below.

시료명 (㎍/ml) Sample name (㎍ / ml) NO 생성량 (%)NO production (%) 대조군Control 11.611.6 ±± 0.20.2 대조군(+ LPS )Control (+ LPS) 100.0 100.0 ±± 1.21.2 감초 추출물Licorice extract + LPS+ LPS 10 10 79.8 79.8 ±± 4.2* 4.2 * 50 50 68.9 68.9 ±± 3.9* 3.9 * 100 100 57.657.6 ±± 5.6* 5.6 * 200 200 46.3 46.3 ±± 5.9* 5.9 * 도라지 클로로포름 분획물Bellflower chloroform fraction 1 One 81.5 81.5 ±± 9.8* 9.8 * 10 10 74.6 74.6 ±± 3.6* 3.6 * 50 50 61.5 61.5 ±± 3.2* 3.2 * 100 100 51.0 51.0 ±± 4.2* 4.2 * 도라지 에틸아세테이트 Bellflower ethyl acetate
분획물Fraction
1 One 79.279.2 ±± 4.2* 4.2 *
10 10 68.3 68.3 ±± 3.0* 3.0 * 100 100 57.0 57.0 ±± 5.0* 5.0 * 200200 45.7 45.7 ±± 5.6* 5.6 * 도라지 부탄올 분획물Bellflower butanol fraction 0.010.01 94.3 94.3 ±± 4.54.5 0.10.1 92.9 92.9 ±± 0.9* 0.9 * 1 One 88.5 88.5 ±± 1.0* 1.0 * 1010 87.8 87.8 ±± 2.6* 2.6 * 도라지 물 분획물Bellflower water fraction 1 One 91.3 91.3 ±± 3.5* 3.5 * 10 10 88.0 88.0 ±± 2.2* 2.2 * 5050 90.5 90.5 ±± 1.9* 1.9 * 100 100 92.2 92.2 ±± 1.7* 1.7 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 13]에 나타난 바와 같이 NO생성 저해활성은 도라지 클로로포름, 에틸아세테이트 분획물은 NO 생성량이 농도 의존적으로 감소하는 경향을 나타내었다. 도라지 부탄올, 물 분획물은 NO 생성저해 효과가 클로로포름 분획물과 에틸아세테이트 분획물에 비해 높지는 않았으나 모든 분획물에서 그 활성을 확인할 수 있었다. 활성이 가장 높은 도라지 에틸 아세테이트 분획물은 항염증 효능이 높다고 알려져 있는 감초추출물과 비교하였을 때, 거의 유사한 NO 생성량 감소 효과를 확인할 수 있었다. 클로로포름 분획물도 에틸아세테이트 분획물과 비슷한 높은 생성 저해능을 보여 주었다.As shown in [Table 13], the inhibitory activity for NO production was a chloroform, and the ethyl acetate fraction showed a tendency of concentration-dependent decrease in NO production. In the bellflower butanol and water fractions, the inhibitory effect of NO production was not higher than that of the chloroform fraction and the ethyl acetate fraction, but the activity was confirmed in all fractions. When compared to the licorice extract, which is known to have a high anti-inflammatory effect, the bellflower ethyl acetate fraction having the highest activity was found to have a similar effect of reducing NO production. The chloroform fraction also showed high production inhibitory activity similar to that of the ethyl acetate fraction.

2). PGE2 생성 저해활성 시험2). PGE 2 production inhibitory activity test

상기 NO 생성 저해활성 시험결과에 의해 NO 생성저해효과가 뛰어난 도라지 에틸아세테이트 분획물 및 도라지 클로로포름 분획물로 PGE2 생성저해효과를 실험하였으며 그 결과를 아래 [표 14] 및 [도 11]로 나타내었다.Based on the NO production inhibitory activity test results, the PGE 2 production inhibitory effect was tested with a bellflower ethyl acetate fraction and a bellflower chloroform fraction having excellent NO production inhibitory effects, and the results are shown in [Table 14] and [FIG. 11] below.

시료명 (㎍/ml) Sample name (㎍ / ml) Prostaglandin EProstaglandin E 22 저해 활성 Inhibitory activity 대조군Control 34.634.6 ±± 1.81.8 대조군 (+ LPS)Control (+ LPS) 100.0100.0 ±± 5.05.0 감초 추출물 Licorice extract +LPS+ LPS 50 50 84.384.3 ±± 2.1* 2.1 * 100 100 67.267.2 ±± 1.4* 1.4 * 도라지 에틸 아세테이트 분획물Bellflower ethyl acetate fraction 1 One 80.580.5 ±± 1.6* 1.6 * 10 10 67.867.8 ±± 3.5* 3.5 * 100100 67.367.3 ±± 2.0* 2.0 * 200200 63.263.2 ±± 4.3* 4.3 * 도라지 클로로포름 분획물Bellflower chloroform fraction 1One 74.374.3 ±± 2.4* 2.4 * 1010 67.567.5 ±± 2.2* 2.2 * 5050 76.376.3 ±± 1.4* 1.4 * 100100 95.995.9 ±± 0.90.9 * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 14]에 나타난 바와 같이 클로로포름 분획물은 PGE2 생성량이 대조군에 비해 1, 10, 50 ㎍/ml 농도에서 변화가 있었으나 유의성을 확인하기 어려웠고, 도라지 에틸아세테이트 분획물은 감초추출물 100㎍/㎖ 농도에서 36.8%와 32.8% 저해되어, NO 생성 저해활성과 거의 비슷한 결과를 보여주었다.As shown in [Table 14], in the chloroform fraction, the amount of PGE 2 production was changed at concentrations of 1, 10, and 50 μg / ml compared to the control group, but it was difficult to confirm the significance, and the bellflower ethyl acetate fraction had a concentration of 100 μg / ml licorice extract In 36.8% and 32.8%, it showed almost similar results to NO production inhibitory activity.

<시험예 9>도라지 분획물들의 항균활성 시험<Test Example 9> Antibacterial activity test of bellflower fractions

비듬(Dandruff)은 주로 두피에서 각질층의 탈락에 의해 쌀겨 모양의 인설이 일어나는 현상으로 건선, 지루성 피부염의 경미한 증상으로 간주되기도 한다. 비듬을 일으키는 원인 중 하나는 Malassezia furfur (M. furfur) 곰팡이 균의 급속 번식으로 오랫동안 피부에 서식하여 특정 조건에서 피부의 표면 감염을 일으키는 원인으로 두피염과 지루성 피부염, 습진, 비듬, 가려움증, 탈모, 여드름 등을 유발하므로 도라지 분확물의 여드름균 및 비듬균에 대한 항균활성효과를 관찰하였다.Dandruff is a phenomenon in which rice bran-shaped sclerosis occurs mainly due to the delamination of the stratum corneum from the scalp, and may be regarded as a minor symptom of psoriasis and seborrheic dermatitis. One of the causes of dandruff is the rapid reproduction of Malassezia furfur ( M. furfur ) fungi, which inhabit the skin for a long time and cause surface infection of the skin under certain conditions.Scalpitis, seborrheic dermatitis, eczema, dandruff, itching, hair loss, Since it causes acne, we observed the antibacterial activity effect of the bellflower extract against acne and dandruff.

1).항균 실험 균주 및 배양 1) .Antibacterial test strain and culture

본 실험에 사용된 균주는 Propionibacterium acnes (P. acnes, 여드름 균)와 Malassezia furfur (M. furfur, 비듬균)으로 미생물자원센터 KCTC (Korean Collection for Type Cultures)에서 분양받아 실험에 사용하였다. P. acnes 생육배지로는 아래 [표 A]로 나타낸 Reinforced Clostridial Medium 을 사용하였으며, M. furfur 생육배지로는 아래 나타낸 [표 B]를 사용하여 배양하였다.The strains used in this experiment were propionibacterium acnes ( P. acnes , acne fungus) and Malassezia furfur ( M. furfur , dandruff), which were distributed in the Microbial Resource Center KCTC (Korean Collection for Type Cultures) and used in the experiment. Reinforced Clostridial Medium shown in [Table A] below was used as the growth medium for P. acnes , and cultured using [Table B] shown below as M. furfur growth medium.

[표 A]Table A

Figure pat00003
Figure pat00003

[표 B]Table B

Figure pat00004
Figure pat00004

2). 항균 활성 측정 2). Antibacterial activity measurement

항균활성 측정은 P. acnesM. furfur 균주를 이용하여 시료의 paper disc diffusion 방법을 이용하였다. 배양된 균주의 단일 colony를 취하여 액체배지에 접종한 후 P. acnesM. furfur를 37℃에서, 48 시간 이상 배양한 다음 1000㎕씩 취해서 고체배지에 균일하게 도말하였다. 멸균된 disc paper (Toyo seisakusho, 8 mm)를 준비하고 각 시료 200㎍/㎖ 농도로 25, 50㎕씩을 접종하여 항균활성을 측정하여 나타내었다. 그 결과 아래 [그림1]로 나타낸 바와같이 분획물들 중에서 에틸아세테이트 분획물과 클로로포름 분획물을 25㎕ 처리하였을 때 0.2cm, 0.5cm의 클리어존을 형성하였고, 50㎕ 처리하였을 때, 아래 0.8cm, 0.7cm의 클리어존을 형성하였다. 에틸아세테이트와 클로로포럼 분획물에서 높은 항균 활성을 측정하여 탈모의 원인이 되는 비듬균에 대한 항균활성을 확인할 수 있었다(참고 아래 그림1의 도라지 분획물들의 비듬균 항균활성 사진에서 상측은 25㎕, 하측은 50㎕이다).To measure the antibacterial activity, a paper disc diffusion method of the sample was used using P. acnes and M. furfur strains. After taking a single colony of the cultured strain and inoculating it in a liquid medium, P. acnes and M. furfur were cultured at 37 ° C. for over 48 hours, and then 1000 μl was taken and uniformly plated on a solid medium. A sterilized disc paper (Toyo seisakusho, 8 mm) was prepared and inoculated with 25, 50 μl of each sample at a concentration of 200 μg / ml to measure antibacterial activity. As a result, a clear zone of 0.2 cm and 0.5 cm was formed when 25 μl of ethyl acetate fraction and chloroform fraction were treated among the fractions, as shown in [Figure 1] below, and when 0.8 μl treatment, 0.8 cm and 0.7 cm below. A clear zone was formed. Antibacterial activity against dandruff which is a cause of hair loss was confirmed by measuring high antibacterial activity in ethyl acetate and chloroforum fractions (in the picture below, in the photo of the antibacterial activity of dandruff of the bellflower fractions in Figure 1, 25 μl in the upper part and 50 μl in the lower part) to be).

[그림 1][Figure 1]

Figure pat00005
Figure pat00005

<시험예 9> 도라지 분획물들의 모두유세포 증식효능 시험 <Test Example 9> All cells of the bellflower fraction proliferation efficacy test

1). 세포독성시험 One). Cytotoxicity test

상기 <시험예 4> 과 동일한 방법에 따라 도라지 분획물들을 모유두세포에 대한 증식효능을 확인하기 위해 1, 10, 50, 100, 200㎍/㎖의 농도로 처리하여 독성을 확인하였다. 비교대조군으로 Finasteride를 사용하였으며 그 결과를 아래 [표 15] 및 [도 12]로 나타내었다.  According to the same method as in <Test Example 4>, the bellflower fractions were treated with concentrations of 1, 10, 50, 100, and 200 µg / ml to confirm the proliferative effect on the dermal papilla cells, thereby confirming toxicity. Finasteride was used as a comparative control, and the results are shown in [Table 15] and [Figure 12] below.

시료명 (㎍/ml)Sample name (㎍ / ml) Cell Viability (%)Cell Viability (%) Control 군Control group 100.0100.0 ±± 0.00.0 도라지 클로로포름Bellflower chloroform
분획물 Fraction
1One 106.4106.4 ±± 11.011.0
1010 107.8107.8 ±± 1.8* 1.8 * 50 50 60.460.4 ±± 2.7* 2.7 * 100100 54.754.7 ±± 2.1* 2.1 * 200 200 54.054.0 ±± 1.1* 1.1 * 도라지 에틸 아세테이트 분획물Bellflower ethyl acetate fraction 1One 97.797.7 ±± 1.21.2 1010 87.487.4 ±± 1.6* 1.6 * 50 50 76.176.1 ±± 7.7* 7.7 * 100100 76.176.1 ±± 10.1* 10.1 * 200 200 77.577.5 ±± 3.3* 3.3 * 도라지 부탄올 분획물Bellflower butanol fraction 1One 100.2100.2 ±± 2.82.8 1010 88.788.7 ±± 1.9* 1.9 * 50 50 62.862.8 ±± 2.1* 2.1 * 100100 44.744.7 ±± 0.6* 0.6 * 200 200 43.443.4 ±± 0.6* 0.6 * 도라지 물 분획물Bellflower water fraction 1One 95.095.0 ±± 3.13.1 1010 101.4101.4 ±± 3.63.6 50 50 99.999.9 ±± 2.92.9 100100 103.4103.4 ±± 6.56.5 200 200 104.9104.9 ±± 3.53.5 FinasterideFinasteride 1One 106.7106.7 ±± 1.3* 1.3 * 1010 105.3105.3 ±± 4.84.8 50 50 99.999.9 ±± 3.63.6 100100 100.9100.9 ±± 3.63.6 200 200 79.479.4 ±± 4.7* 4.7 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기 [표 15]에 나타난 바와같이 도라지 물 분획물과 Finasteride를 제외하고 거의 대부분의 농도에서 독성이 나타났다. As shown in [Table 15], toxicity was observed at most concentrations except for the bellflower water fraction and Finasteride.

2). 모유두세포 재생효과 시험  2). Hair papilla regeneration effect test

모유두세포 재생효과 시험는 상기 세포독성시험의 결과에서 독성효과가 나타나지 않은 도라지 물 분획물만으로 모유두세포 재생활성을 시험하였으며, 도라지 물 분획물은 시료 미처리 대조군과 1일, 2일, 3일간 배양하면서 대조군에 대한 세포 증식율을 측정하였다.   In the results of the cytotoxicity test, the dermal papilla cell regeneration effect test was performed to test the dermal papilla cell regeneration activity only with a bellflower water fraction that did not show a toxic effect. Cell proliferation rate was measured.

그 결과 아래 [표 16]에 나타난 바와같이 도라지 물 분획물은 1일, 2일 3일 배양 시 50㎍/㎖ 이상의 농도에서 유의적인 세포증식능을 확인할 수 있었으며, 200㎍/㎖ 의 농도에서는 16.9%의 세포 증식능을 보여주었다. 같은 농도에서 2일에는 17.7%, 3일에는 18.2%의 증식활성을 나타냈다. 세포 배양기일의 증가에 따른 높은 증가율을 보여주지는 않았다.As a result, as shown in [Table 16], the bellflower water fraction was found to have a significant cell proliferation capacity at a concentration of 50 μg / ml or more when cultured for 1 day, 2 days, 3 days, and 16.9% at a concentration of 200 μg / ml. Cell proliferation ability was shown. At the same concentration, 17.7% on day 2 and 18.2% on day 3 showed proliferative activity. It did not show a high rate of increase with increasing cell culture period.

시료명 (㎍/ml)Sample name (㎍ / ml) 모유두세포 세포증식율 (%)Breast papilla cell proliferation rate (%) 1일1 day 2일2 days 3일3 days ControlControl 100.0 100.0 ±± 0.50.5 100.0100.0 ±± 6.86.8 100.0100.0 ±± 4.84.8 도라지 물 분획물Bellflower water fraction 10 10 103.3103.3 ±± 4.54.5 108.2108.2 ±± 5.75.7 107.2 107.2 ±± 4.24.2 50 50 110.3 110.3 ±± 2.3* 2.3 * 109.3 109.3 ±± 5.5* 5.5 * 115.0 115.0 ±± 5.6* 5.6 * 100 100 112.9 112.9 ±± 8.3* 8.3 * 113.3 113.3 ±± 5.6* 5.6 * 115.8 115.8 ±± 2.0* 2.0 * 200 200 116.9 116.9 ±± 6.6* 6.6 * 117.7 117.7 ±± 2.3* 2.3 * 118.2 118.2 ±± 3.8* 3.8 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

<시험예 10> 도라지 분획물들의 Dihydrotestosterone 생성 저해활성 시험<Test Example 10> Dihydrotestosterone production inhibitory activity test of bellflower fractions

탈모의 원인이 된다고 알려진 Dihydrotestosterone의 생성 저해능을 측정하여 분획물의 탈모 예방 효능을 측정해 보았다. 래트의 간 균질액을 5알파 리덕테이즈가 다량 함유된 레트의 간 균질액을 효소액으로 하여 균질액에 시료를 처리한 후 배양하여 Dihydrotestosterone의 생성량을 측정하였다.  The effect of preventing the hair loss of the fraction was measured by measuring the inhibitory ability of Dihydrotestosterone, which is known to cause hair loss. The liver homogenate of the rat was treated with the homogenate of the rat homogenate containing a large amount of 5 alpha reductase as an enzyme solution and then cultured to measure the amount of dihydrotestosterone produced.

아래 [표 17]에 나타난 바와같이 에틸아세테이트 분획물은 50㎍/㎖와 10㎍/㎖의 농도에서 20% 정도의 저해활성을 보여주었으며, 도라지 부탄올 분획물은 농도의존적인 활성 저해능은 확인할 수 없었다.As shown in [Table 17], the ethyl acetate fraction showed inhibitory activity of about 20% at the concentrations of 50 µg / ml and 10 µg / ml, and the bellflower butanol fraction could not confirm the activity-dependent inhibitory activity.

아래 [표 18]에 나타난 바와같이 도라지 클로로포름 분획물은 시료 미처리 대조군에 비해 100㎍/㎖의 농도에서 48.4%의 높은 감소효과를 보여주어 분획물중에서 가장 효과가 좋았다. DHT생성을 저해하는 것으로 알려진 Finasteride는 100㎍/㎖ 농도에서 51.5%의 저해 활성을 보여주어 도라지 클로로포름 분획물과 거의 비슷한 효과를 나타내어 매우 높은 DIhydrotestosterone 생성 저해효능을 확인할 수 있었다. As shown in [Table 18] below, the bellflower chloroform fraction showed a high reduction effect of 48.4% at a concentration of 100 µg / ml compared to the sample-untreated control group, and was the most effective among the fractions. Finasteride, which is known to inhibit DHT production, showed an inhibitory activity of 51.5% at a concentration of 100 μg / ml, showing almost the same effect as that of the bellflower chloroform fraction, thereby confirming the very high inhibitory effect of DIhydrotestosterone production.

시료(㎍/ml)Sample (µg / ml) Dihydrotestosterone (%)Dihydrotestosterone (%) ControlControl 109.1109.1 ±± 1.21.2 도라지 에틸 아세테이트 분획물Bellflower ethyl acetate fraction 1 One 127.6127.6 ±± 3.0* 3.0 * 1010 101.6101.6 ±± 1.2* 1.2 * 5050 83.983.9 ±± 3.7* 3.7 * 100100 80.880.8 ±± 5.7* 5.7 * 도라지 부탄올 분획물Bellflower butanol fraction 1One 71.371.3 ±± 12.3* 12.3 * 1010 81.981.9 ±± 8.7* 8.7 * 5050 76.176.1 ±± 1.7* 1.7 * 100100 82.482.4 ±± 3.2* 3.2 * * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

시료(㎍/ml)Sample (µg / ml) Dihydrotestosterone (%)Dihydrotestosterone (%) ControlControl 100.0100.0 ±± 5.45.4 도라지 클로로포름 분획물Bellflower chloroform fraction 1 One 67.467.4 ±± 2.4* 2.4 * 1010 63.363.3 ±± 7.3* 7.3 * 5050 64.764.7 ±± 3.7* 3.7 * 100100 51.651.6 ±± 2.0* 2.0 * FinasterideFinasteride 1One 100.0100.0 ±± 0.90.9 1010 68.568.5 ±± 2.5* 2.5 * 100100 48.548.5 ±± 2.8* 2.8 * 간 (무반응)Liver (no reaction) 107.5107.5 ±± 1.51.5 * : p < 0.05, Control 군과 비교*: p <0.05, compared with Control group

상기한 <시험예>들의 결과에 의해 본 발명에 따른 도라지 추출물과 분획물들은 항산화 효과와 피부세포 재생효과, NO 및 PGE2 생성을 줄이는 항염증효과, 탈모의 원인이 되는 Dihydro- testosterone 생성저해 효과를 보여주어 탈모방지 천연추출물로의 가능성을 확인할 수 있고 또 도라지 클로로포름과 에틸아세테이트 분획물은 비듬균의 생육을 억제하는 항균활성효과가 있었고, 모유두세포 증식효능도 확인하였고, DHT 생성량을 50% 가까이 감소시키는 효과가 있는 것을 알 수 있으므로 본 발명에 따른 도라지 추출물 및 분획물들이 탈모방지 및 발모효과를 나타내는 것을 예측할 수 있으며 또한 탈모방지 및 발모 위한 헤어 케어 제품에 본 발명의 도라지 추출물 및 분획물들을 적용할 수 있는 것을 예측할 수가 있다.According to the results of the above <Test Examples>, the bellflower extract and fractions according to the present invention have an antioxidant effect and a skin cell regeneration effect, an anti-inflammatory effect that reduces NO and PGE 2 production, and a dihydro-testosterone production inhibitory effect that causes hair loss. It showed that it is possible to confirm the potential as a natural extract to prevent hair loss, and the bellflower chloroform and ethyl acetate fraction had antibacterial activity effects to inhibit the growth of dandruff bacteria, confirmed the effect of proliferating the papillary cells, and reduced the amount of DHT production by 50% Since it can be seen that there is a bellflower extract and fractions according to the present invention can predict that the hair loss prevention and hair growth effect, and also predict that the bellflower extract and fractions of the present invention can be applied to the hair care product for hair loss prevention and hair growth Can be.

Claims (8)

도라지 추출물 또는 도라지 추출물로부터 수득된 도라지 분획물을 유효성분으로 함유하는 것을 특징으로 하는 탈모예방 및 발모개선 조성물.A hair loss prevention and hair growth improvement composition comprising a bellflower extract or a bellflower fraction obtained from a bellflower extract as an active ingredient. 청구항 1에 있어서, 도라지 추출물은 도라지 에탄올 추출물이고, 도라지 분획물은 도라지 클로르포름 분획물, 도라지 에틸아세테이트 분획물, 도라지 부탄올 분획물 및 도라지 물 분획물 중에서 선택되는 어느 하나 이상의 분획물인 것을 특징으로 하는 탈모예방 및 발모개선 조성물.The method according to claim 1, wherein the bellflower extract is a bellflower ethanol extract, the bellflower fraction is any one or more fractions selected from bellflower chlorform fraction, bellflower ethyl acetate fraction, bellflower butanol fraction and bellflower water fraction, preventing hair loss and improving hair growth. Composition. 청구항 1 또는 청구항2에 있어서, 유효성분이 조성물 총중량에 대하여 0.1 내지 80중량% 함유하는 것을 특징으로 하는 탈모예방 및 발모개선 조성물.The method for preventing hair loss and improving hair growth according to claim 1 or 2, wherein the active ingredient contains 0.1 to 80% by weight based on the total weight of the composition. 청구항 3에 있어서, 유효성분이 DPPH 라디칼 소거능을 갖는 것을 특징으로 하는 탈모예방 및 발모개선 조성물.The method for preventing hair loss and improving hair growth according to claim 3, wherein the active ingredient has a DPPH radical scavenging ability. 청구항 3에 있어서, 유효성분이 ABTS 라디칼 소거능을 갖는 것을 특징으로 하는 탈모예방 및 발모개선 조성물.The method for preventing hair loss and improving hair growth according to claim 3, wherein the active ingredient has an ABTS radical scavenging ability. 청구항 3에 있어서, 유효성분이 항산화 활성을 갖는 것을 특징으로 하는 탈모예방 및 발모개선 조성물. The method for preventing hair loss and improving hair growth according to claim 3, wherein the active ingredient has antioxidant activity. 청구항 3에 있어서, 유효성분이 일산화질소(Nitric Oxide) 생성 저해능을 갖는 것을 특징으로 하는 탈모예방 및 발모개선 조성물.The method for preventing hair loss and improving hair growth according to claim 3, wherein the active ingredient has the ability to inhibit the production of nitrogen monoxide. 청구항 3에 기재된 탈모예방 및 발모개선 조성물이 헤어토닉, 헤어컨디셔너, 헤어에센스, 헤어로션, 헤어영양로션, 헤어샴푸, 헤어린스, 헤어트리트먼트, 헤어크림, 헤어영양크림, 헤어모이스처크림, 헤어맛사지크림, 헤어왁스, 헤어 에어로졸, 헤어팩, 헤어영양팩, 헤어비누, 헤어클렌징폼, 머릿기름, 모발건조제, 모발보존처리제, 모발염색제, 모발용 웨이브제, 모발탈색제, 헤어겔, 헤어글레이즈, 헤어드레싱어, 헤어래커, 헤어모이스처라이저, 헤어무스 및 헤어스프레이 중 어느 하나의 제형으로 이루어진 것을 특징으로 하는 탈모예방 및 발모개선 조성물.
The hair loss prevention and hair growth improvement composition according to claim 3 is hair tonic, hair conditioner, hair essence, hair lotion, hair nutrition lotion, hair shampoo, hair rinse, hair treatment, hair cream, hair nutrition cream, hair moisture cream, hair massage Cream, hair wax, hair aerosol, hair pack, hair nutrition pack, hair soap, hair cleansing foam, hair oil, hair drying agent, hair preservative, hair dye, hair wave agent, hair bleach, hair gel, hair glaze, hair dresser, Hair lacquer, hair moisturizer, hair mousse, and hair loss prevention and hair growth improvement composition, characterized in that made of any one of the formulation.
KR1020180143660A 2018-11-20 2018-11-20 Hair loss prevention and hair growth improving composition containing a bellflower extract or a bellflower fractio KR20200058932A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180143660A KR20200058932A (en) 2018-11-20 2018-11-20 Hair loss prevention and hair growth improving composition containing a bellflower extract or a bellflower fractio

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180143660A KR20200058932A (en) 2018-11-20 2018-11-20 Hair loss prevention and hair growth improving composition containing a bellflower extract or a bellflower fractio

Publications (1)

Publication Number Publication Date
KR20200058932A true KR20200058932A (en) 2020-05-28

Family

ID=70919989

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180143660A KR20200058932A (en) 2018-11-20 2018-11-20 Hair loss prevention and hair growth improving composition containing a bellflower extract or a bellflower fractio

Country Status (1)

Country Link
KR (1) KR20200058932A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023055054A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having activity for preventing hair loss or promoting hair growth, and use thereof
WO2023055055A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having hair loss prevention or hair growth promotion activity, and use thereof
WO2023055053A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having hair loss prevention or hair growth promotion activity and use thereof
WO2023055051A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having activity of preventing hair loss or promoting hair growth, and use thereof
WO2023055060A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having activity of preventing hair loss or promoting hair growth, and use thereof
WO2023055056A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having activity of preventing hair loss or promoting hair growth and use thereof
KR20230064365A (en) * 2021-11-03 2023-05-10 동의대학교 산학협력단 Composition for preventing or improving gray hair and hair loss comprising extracts from saussurea neoserrata

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101009763B1 (en) 2008-07-24 2011-01-19 주식회사 코스메카코리아 Natural and oriental herbs complex with anti-hairloss and hair growth stimulating effects
KR101440046B1 (en) 2012-04-13 2014-09-26 박진미 Oriental composition for preventing loss of hair and promoting growth of hair, and method of preparing the same
KR101758998B1 (en) 2015-11-12 2017-07-17 (주) 벤우코리아 Composition for preventing hair loss and improving hair growth comprising plant extract

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101009763B1 (en) 2008-07-24 2011-01-19 주식회사 코스메카코리아 Natural and oriental herbs complex with anti-hairloss and hair growth stimulating effects
KR101440046B1 (en) 2012-04-13 2014-09-26 박진미 Oriental composition for preventing loss of hair and promoting growth of hair, and method of preparing the same
KR101758998B1 (en) 2015-11-12 2017-07-17 (주) 벤우코리아 Composition for preventing hair loss and improving hair growth comprising plant extract

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023055054A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having activity for preventing hair loss or promoting hair growth, and use thereof
WO2023055055A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having hair loss prevention or hair growth promotion activity, and use thereof
WO2023055053A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having hair loss prevention or hair growth promotion activity and use thereof
WO2023055051A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having activity of preventing hair loss or promoting hair growth, and use thereof
WO2023055060A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having activity of preventing hair loss or promoting hair growth, and use thereof
WO2023055056A1 (en) 2021-10-01 2023-04-06 (주)케어젠 Peptide having activity of preventing hair loss or promoting hair growth and use thereof
KR20230047692A (en) 2021-10-01 2023-04-10 (주)케어젠 Peptide having hair loss preventing activity or hair growth promoting activity and use thereof
KR20230047693A (en) 2021-10-01 2023-04-10 (주)케어젠 Peptide having hair loss preventing activity or hair growth promoting activity and use thereof
KR20230047691A (en) 2021-10-01 2023-04-10 (주)케어젠 Peptide having hair loss preventing activity or hair growth promoting activity and use thereof
KR20230047690A (en) 2021-10-01 2023-04-10 (주)케어젠 Peptide having hair loss preventing activity or hair growth promoting activity and use thereof
KR20230047689A (en) 2021-10-01 2023-04-10 (주)케어젠 Peptide having hair loss preventing activity or hair growth promoting activity and use thereof
KR20230047688A (en) 2021-10-01 2023-04-10 (주)케어젠 Peptide having hair loss preventing activity or hair growth promoting activity and use thereof
KR20230064365A (en) * 2021-11-03 2023-05-10 동의대학교 산학협력단 Composition for preventing or improving gray hair and hair loss comprising extracts from saussurea neoserrata

Similar Documents

Publication Publication Date Title
KR20200058932A (en) Hair loss prevention and hair growth improving composition containing a bellflower extract or a bellflower fractio
KR101877801B1 (en) Composition of skin external application containing ginsenoside F2 derive from hydroponic ginseng
EP2335685A1 (en) Skin-whitening agent, anti-aging agent, and skin cosmetic
KR101704874B1 (en) Cosmetic Compositions with Whitening and Anti-oxidative Effect Comprising of Phragmitis Rhizoma, Salicomia herbacea L. and Prunus mume
KR101928797B1 (en) Composition of skin external application containing compound K
KR101985884B1 (en) Skin external composition comprising flower vinegar extract
JP2005035911A (en) Maillard reaction inhibitor
KR102063686B1 (en) Skin external composition containing extract of soybean root
JP6077560B2 (en) Skin external preparation composition containing white-bellied extract
KR102415369B1 (en) Functional bath cleanser composition comprising plant powder
KR102021764B1 (en) Skin external composition containing ginsenoside Rh4
KR20080093500A (en) Cosmetic compositions for preventing skin aging comprising extract astilbe chinensis var. davidii
KR20210024357A (en) Antioxidant and moisturizing cosmetic composition containing mixed extracts including Prunus yedoensis flower, Peach tree flower and Chrysanthemum flower extract
JPH01102011A (en) Skin cosmetic
KR20180100093A (en) Composition of skin external application containing ginsenoside F1
JP5190083B2 (en) S100A8 expression regulator
KR101939111B1 (en) Composition of skin external application containing ginsenoside F2
KR102348714B1 (en) A cosmetic composition for antioxidant and wrinkle improvement containing a mixed extract comprising Sorbus commixta branch, Sorbus commixta fruit, Elsholtzia splendens flower and Taraxacum coreanum flower extract
KR100722955B1 (en) The herbal composition having the skin antiaging and antiwrinkling function
KR102171472B1 (en) a Composition for improving Hair growth containing a leaf extract of Dendropanax Morbifera and a extract of Hallabong rind
JPH05155750A (en) Cosmetic
KR20180101707A (en) Composition of skin external application containing ginsenoside F2
KR20200064204A (en) Composition for improving atopic dermatitis containing Dendropanax morbifera Lev. extract
KR102374884B1 (en) Cosmetic composition containing the extract of dendropanax morbifera and wild ginseng as active ingredient
Suzu et al. Antioxidant and Antityrosinase Activity of Cissus quadrangularis Extract

Legal Events

Date Code Title Description
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X601 Decision of rejection after re-examination